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Mothers who deliver a low birth weight infant may themselves be at excess risk for 
cardiovascular disease.  We validated maternal recall of infant birth weight after an average 
follow up of 57 years, and investigated whether older women who reported having delivered low 
birth weight (LBW) infants (<2500 g) had later elevations in cardiovascular risk factors and were 
at increased risk for clinical cardiovascular disease.  Participants were 446 women (mean age 80 
years; 47% black) enrolled in The Health, Aging and Body Composition Study.  Women 
reported birth weight and selected complications for each pregnancy, and pregnancies 
complicated by hypertension or preeclampsia were excluded.  We found strong correlation 
between recalled and documented birth weights for first births (ICC=0.96) in a randomly 
selected group of participants, and reliability of recall for first births remained high when 
considered separately by race, education, income and age.  Women who had reported a LBW 
first birth had a lower current BMI (adjusted for race and age) compared to women with normal 
weight infants (26.6 vs. 28.0 kg/m²; p=0.057), but they had a higher abdominal circumference 
(98.1 vs. 95.0 cm; p=0.007).  After adjustment for BMI, race and age, women with a history of a 
LBW vs. normal weight infant had elevated systolic blood pressures (p=0.048) despite higher 
use of anti-hypertensive medication (p=0.061).  Women with LBW infants also had higher levels 
of IL-6 (p=0.021), fasting insulin (p=0.064), and triglycerides (p=0.071), and they were more 
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insulin resistant (p=0.045) compared to women with a normal weight infant.  Women who 
delivered preterm infants had an elevated risk for cardiovascular disease at age 80 (adjusted odds 
ratio=2.77, 95% CI 1.06-7.24) compared to women who delivered term infants.  Women who 
had delivered infants both LBW and preterm had markedly elevated cardiovascular risk factors 
when compared to women with normal weight term infants, and appeared to have the highest 
risk for clinical cardiovascular disease (adjusted odds ratio=4.21, 95% CI 1.23-14.45).  The 
public health importance of these findings is that a history of LBW or preterm delivery may 
identify women who would benefit from screening and intervention aimed at risk factors for 
cardiovascular disease. 
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1. INTRODUCTION 
 
1.1. SPECIFIC AIMS 
 
 Emerging evidence suggests that mothers who deliver a growth restricted or preterm 
infant may themselves be at excess cardiovascular risk.  Two large observational studies have 
found that low birth weight (<2500 g.) delivery may increase risk for cardiovascular disease 
seven to 11-fold. [1, 2]  In addition, two studies found that risk for cardiovascular death was 
twice that for women with a history of preterm delivery compared to those who had delivered at 
term.  [3, 4] 
 The study of cardiovascular disease in women has focused typically on traditional risk 
factors that women share with men.  Women, however, experience gender specific exposures 
that may affect cardiovascular risk, such as pregnancy.  The Health, Aging, and Body 
Composition (Health ABC) Study is a large on-going epidemiologic study of how changes in 
body composition affect morbidity, disability and risk of mortality.  This cohort is ideally suited 
to study the association between pregnancy history and maternal cardiovascular risk as there are 
extensive outcome data already collected, participants continue to be contacted annually, and 
they are racially diverse. 
 Pregnancy history data are limited in the main Health ABC study, so this study will 
collect these data retrospectively through participant interview.  We hypothesize that delivery of 
a small or preterm infant will act as a marker of women at increased risk for cardiovascular 
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 disease.  In addition, we hypothesize that a poor pregnancy outcome of low birth weight or 
preterm delivery will interact with other risk factors across a woman’s lifetime to elevate her 
future risk for cardiovascular disease. 
 It is important to test these hypotheses in a group of women with detailed clinical 
cardiovascular risk data to determine if the association is spurious or real.  If an association 
exists between infant birth weight and future cardiovascular disease, this may provide an early 
marker of women who should be targeted for interventions long before clinical manifestation of 
disease.  In addition, understanding how maternal chronic disease risks might be involved in 
mechanisms leading to low birth weight or preterm delivery could provide important insight into 
these persistent public health challenges.   
 This is a cross-sectional study designed to examine the association between delivery of a 
low birth weight (< 2500 g) infant and cardiovascular morbidity to achieve the following 
scientific objectives: 
1. To assess whether women who have born a low birth weight infant have later elevations 
in blood pressure, lipid profiles, glucose concentrations, IL-6, CRP and pulse wave 
velocity. 
2. To determine if women who delivered a low birth weight or preterm infant have an 
increased risk of coronary artery disease, stroke or peripheral vascular disease compared 
with women who delivered a normal weight infant. 
3. To determine how birth outcomes might interact with other risk factors over the course of 
a woman’s lifetime, such as obesity, race and smoking, to mediate risk for cardiovascular 
disease. 
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 1.2. BACKGROUND AND SIGNIFICANCE 
 
1.2.1. Epidemiology of low birth weight and preterm delivery 
 Low birth weight (LBW) has been considered the most important newborn characteristic 
predicting infant mortality. [5-7]  LBW has also been associated with long term morbidity in 
children, including mental retardation, cerebral palsy, sensory perception, school performance, 
and overall quality of life. [8]  In addition, delivery of one LBW or preterm infant is the single 
strongest predictor of subsequent LBW or preterm delivery. [9] 
 Low birth weight newborns are defined by the World Health Organization (WHO) as 
those weighing less than 2500 g. at birth.  LBW and preterm delivery (before 37 weeks 
gestation) are intimately related; 60% of LBW births were also preterm. [10]  LBW can also 
result from intrauterine growth restriction (IUGR) in infants born at or near term.  IUGR refers to 
a biological phenomenon of restricted growth relative to the genetic potential of an infant.  Small 
for gestational age (SGA) is a statistical phenomenon typically categorized as infants at the 
bottom 10th percentile for weight for a given gestational age, [11] and is often used as a proxy for 
IUGR.  It is estimated that 4 to 8% of all infants are growth restricted, and 25 to 33% of LBW 
infants have sustained IUGR. [12] IUGR and/or preterm infants can be classified in the 
following categories: [12] 
Table 1:  Classification of Preterm and Growth Restricted Infants 
Category Definition 
Preterm neonates Newborns delivered before 37 completed 
weeks gestation who are of appropriate size for 
gestational age 
Preterm and growth-restricted Newborns delivered before 37 completed 
weeks gestation who are small for gestational 
age 
Term growth-restricted Newborns delivered after 37 completed weeks 
gestation who are small for gestational age 
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Classifying newborns in this way, however, requires an accurate birth weight as well as 
an accurate determination of gestational age.  Gestational age determination requires a 
combination of antepartum ultrasound results and date of last menstrual period, and these clinical 
data are not always available.  Epidemiologic studies must at times rely on birth weight as a 
marker for prematurity or growth restriction because accurate gestational age data may not be 
available.   
The rate of low birth weight resulting from both IUGR and/or preterm delivery in the 
U.S. has gone from 7.9% in 1970 to 6.8% in 1980 to 7.7% in 2001. [13] Rates are increasing for 
white women, but rates for black women continue to be more than double those of whites.  The 
rate of preterm delivery is higher than LBW and on the increase; preterm delivery rates were 
9.8% in 1985 and 12.1% in 2002. [14] Infants born both preterm and LBW are at greatest risk for 
morbidity, mortality and disabilities. [10] 
 Causes of preterm delivery are mutifactorial, with about 40% of cases due to premature 
spontaneous labor, 40% due to premature rupture of membranes, and 20% due to fetal or 
maternal indication. [8] The mechanisms that lead to preterm delivery or LBW are thought to fall 
into several different pathologic pathways that involve both endogenous and exogenous 
exposures. [12] The following chart summarizes the action along these possible pathways, and is 
adapted from Mattison, et al. [10] 
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Table 2:  Pathways to iatrogenic preterm and/or low birth weight delivery 
Pathway Possible Mechanism 
Familial aggregation The single largest risk factor for preterm delivery is 
previous preterm delivery.  Family studies have 
demonstrated increased risk of preterm delivery and 
LBW among siblings. 
Maternal stress Acute or chronic maternal stress has been suggested 
as increasing risk for preterm delivery.  Thought to 
operate through maternal, placental and fetal 
hormonal mechanisms. 
Fetal stress Fetal stress due to inadequate nutrition, oxygenation, 
or infection may produce hormones signally the onset 
of labor.  Preterm delivery for these reasons may also 
be medically induced, such as with preeclampsia 
Bleeding Bleeding into the myometrium of the uterus acts as a 
stimulant to contractions. 
Inflammation  Initiation of inflammatory responses with release of 
maternal or fetal cytokines, interleukins or molecular 
modulators of inflammation may initiate uterine 
activity.   
Fetal infection Fetal infection is a stressor that appears to initiate 
uterine activity. 
Maternal infection Infection of the uterus, placenta or systemic infection.  
Mechanical Abnormally small uterine cavity, multiple gestation 
or abnormal or incompetent cervix. 
 
It is possible that genotypes and phenotypes implicated in the risk for LBW or preterm 
delivery may also play a role in maternal vascular disease.  Underlying risk for cardiovascular 
disease may affect a woman’s ability to successfully adapt to the vascular or metabolic demands 
of pregnancy, leading to poor pregnancy outcomes during the reproductive years and higher 
cardiovascular risk later in life. [15]  In particular, family aggregation, inflammation and 
infection may be pathways linking these health outcomes. 
1.2.1.1. Familial aggregation 
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  There has been strong evidence that the composite endpoint of low birth weight, resulting 
from IUGR or preterm delivery, aggregates in families.  Wang, et al completed one large study 
that found adjusted odds of a woman delivering LBW after an earlier LBW pregnancy was 6.8 
(95% CI 4.7 to 9.8) for whites and 4.7 (95% CI 3.5 to 6.4) for blacks. [16]  The odds of 
delivering a LBW infant more than doubled when the mother herself was LBW and she had a 
previous LBW pregnancy.  Utilizing data from the Collaborative Perinatal Project, Klebanoff, et 
al found that infants born to mothers who themselves were LBW were on average 244 g. lighter 
than infants of mothers who weighed 8 pounds or more at birth. [6]  Odds of delivering a LBW 
infant when the mother herself was born LBW were 3.46 (95% CI 1.5 to 7.9) compared to the 
reference group of mothers who weighed 8 pounds or more at birth. 
 Reduced placental perfusion, implicated in both IUGR [17] and preterm birth [18], could 
involve both genetic and environmental components that cause these poor pregnancy outcomes 
to aggregate in families.  Roberts and Cooper have suggested a maternal genetic contribution to 
the incomplete remodeling of the spiral arteries resulting in restricted placental perfusion [19], 
and environmental influences such as cigarette smoking could also restrict adequate blood flow 
to the placenta. [20]   
1.2.1.2.  Infection and inflammation 
 
 
 Infection and inflammation have also been strongly associated with preterm delivery, 
especially very early preterm births occurring before 33 weeks completed gestation.  In women 
with spontaneous preterm labor and intact membranes the most common vaginal organisms are 
of relatively low virulence. [21] It appears that these bacteria ascend into the uterus, perhaps 
even prior to pregnancy, and some women may sustain chronic intrauterine infections between 
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 pregnancies which could cause repeated spontaneous preterm deliveries. [22] Goldenberg, et al 
found in the Preterm Prediction Study that risk for spontaneous preterm delivery prior to 32 
weeks was 14.1 (95% CI: 9.3-21.4) times higher for women who tested positive for fetal 
fibronectin compared to those who tested negative. [23] Fetal fibronectin, a protein of the 
placental membranes, is thought to indicate a disruption to the maternal-fetal interface caused by 
infection or inflammation when found in cervical secretions between 22 and 34 weeks gestation. 
[9]  
 Bacterial vaginosis (BV), a disruption in the vaginal flora, has also been associated with 
increased risk for preterm spontaneous labor. [24] A multi-center trial of treatment for BV, 
however, found no effect on reducing rates of preterm delivery suggesting that BV may be a 
marker of infection of inflammation but not a cause of preterm delivery. [25] Thompson, et al 
found that inflammatory cells, predominantly neutorphils and macrophages, infiltrated the 
human myometrium during spontaneous labor at term and likely play a key role in initiating 
spontaneous preterm labor. [26]   
Thus infection and inflammation have been consistently associated with preterm delivery and 
LBW but the mechanisms have not been clearly identified.  This association, especially for very 
preterm or very low birth weight infants, suggests that perhaps some women with a history of 
preterm labor develop a susceptibility to dysregulation of inflammation that persists and could be 
associated with coronary heart disease risk later in life. [27] 
 
1.2.2. Epidemiology of cardiovascular disease in women 
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  Cardiovascular disease is the leading cause of mortality among women in the U.S., 
causing more deaths than all forms of cancer combined. [13] A total of 456,064 women died 
from cardiovascular disease in 2002, accounting for 38.3% of all deaths.  Women on average 
experience cardiovascular mortality about ten years later than men,  [28]  and women’s risk for 
cardiovascular disease increases dramatically after the menopause suggesting that endogenous 
estrogen may play a protective role in women of reproductive age.  It became common clinical 
practice for postmenopausal women to be prescribed exogenous estrogen during the 1990s due to 
observational studies that suggested a cardioprotective benefit.  However, the landmark 
Women’s Health Initiative trial demonstrated that exogenous hormone replacement therapy in 
fact increased a woman’s risk for cardiovascular mortality [29], indicating there is much yet to 
learned about women’s cardiovascular risks.  
There is evidence that cardiovascular risk factors that are elevated in women prior to menopause 
increase proportionally post menopause. [30] Thus, women who have elevated blood pressure, 
LDL cholesterol, triglycerides and BMI and low levels of HDL before menopause remain the 
highest risk after menopause.  This evidence suggests that although cardiovascular risk increases 
dramatically for women after the menopause, high risk women can be identified in the pre- or 
peri-menopausal years.  
 Recent work that pooled results from 14 randomized trials demonstrated that 80 to 90% 
of women and men with CHD have one or more of the conventional risk factors:  smoking, 
diabetes, hyperlipidemia or hypertension. [31] Although the risk factors for cardiovascular 
disease are the same for women and men, their prevalence and magnitude appear to differ.  
Isolated systolic hypertension is of particular concern for older women, [32] and diabetes, low 
HDL cholesterol  and obesity are “meshed together in a tight metabolic complex” that appears to 
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 confer a higher CHD risk in women than men. [33] While diabetes increases coronary heart 
disease risk for women 3 to 7-fold, the magnitude of the risk is decreased to 2 to 3-fold in men. 
[34]  It also appears that while smoking is a risk factor for both men and women, relative risk for 
stroke in women who smoke is 2.12 while the comparable risk for men who smoke is 1.64. [35]   
Women experience a higher fatality rate following a first myocardial infarction.  44% of 
women will have died within one year post-MI compared to 27% of men. [36]  This may be due 
to increase severity of illness, as women present with disease at an advanced age and with more 
co-morbidities.  Despite an overall decline in the cardiovascular death rate in the U.S. over the 
past several decades, the rate of decline has been slower for women compared to men, and less 
for black women compared to white women.  In addition, the death rate from cardiovascular 
disease is 69% higher in black women compared to white women.  Two-thirds of sudden deaths 
due to coronary heart disease occur in women with no previous symptoms, compared to half of 
sudden deaths in men. [32] These data suggest that primary prevention and early detection of 
cardiovascular disease in women are needed. 
 
1.2.3. Reproductive history and cardiovascular disease 
 
 There are profound changes in a woman’s cardiovascular and renal systems to 
accommodate a normal pregnancy, many of which would be considered signs of cardiovascular 
dysfunction during any other time.  Blood volume increases progressively from 6 to 8 weeks 
gestation, peaking at an increase of 45 percent by 32 weeks. [37]  Cardiac output increases by 30 
to 50 percent during pregnancy, with half of this increase occurring very early in pregnancy. In 
addition, pulse rate increases about 17 percent, and there are striking alterations in renal 
physiology.  Although the insulin response to glucose is augmented in early pregnancy, insulin 
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 resistance emerges during the second half of pregnancy. [38] Serum cholesterol increases are 
generally greater than 50 percent during pregnancy, accompanied by increases in triglycerides, 
phospholipids, and lipoproteins. [39]  These increases approach the levels found in patients with 
coronary heart disease.  It has also been documented that normal pregnancy is associated with 
inflammatory changes often as intense as those found in sepsis. [40]  Some women may not 
successfully adapt to these profound changes required to maintain a healthy pregnancy, 
suggesting that pregnancy provides a ‘stress’ test of maternal lipid pathways and vascular 
function. [15] Adverse pregnancy outcomes such as LBW or preterm delivery may in part result 
from this maladaptation, and could be an indicator of an underlying predisposition for future 
metabolic or vascular disease. 
 There is evidence that parity and age at first birth are also associated with cardiovascular 
risk in women.  Ness, et al, examined data from two large cohorts of women and found that high 
parity (six or more pregnancies) was associated with an increase in risk for cardiovascular 
disease. [41] It was hypothesized that insulin resistance may play a role in this association, as it 
is a major risk factor for cardiovascular disease in women. 
 Several studies have demonstrated that levels of HDL cholesterol are reduced after 
pregnancy below pre-pregnancy levels, and remain significantly lower in women with multiple 
pregnancies. [42, 43] It has also been suggested that there may be long term effects of pregnancy 
on fat distribution and obesity that could affect cardiovascular disease risk, [44-46] and that these 
associations may differently affect black and white women. [46]  
 Three studies that examined age at first birth found that women who delivered a first 
birth before age 20 had an increased risk for coronary heart disease compared to women who 
were older.[47-49] Although this has been a consistent finding, no biologic mechanisms have 
10 
 been suggested.  It has been hypothesized that young maternal age may be a marker of other 
sociodemographic risks that are difficult to adequately adjust for, but this has not been 
investigated.  One case control study demonstrated that women who were younger than age 20 at 
their first birth and had five or more pregnancies had a 2.3-fold higher risk for myocardial 
infarction compared to women who were older at their first birth and had fewer pregnancies. [49] 
 The literature on parity and cardiovascular risk suggests that pregnancy has a modest but 
consistent impact women’s long term cardiovascular health.  This body of research also indicates 
that any possible effect must be examined in older women.  Research is conflicting when limited 
to studying cardiovascular disease in younger cohorts of women, perhaps due to the fact that risk 
for women accelerates after menopause. [50]  Our study will examine the possible association of 
specific reproductive exposures (low birth weight and preterm delivery) and cardiovascular risk 
in older women.  Adjustment will be made for parity and age at first birth along with traditional 
cardiovascular risk factors. 
1.2.3.1. Preeclampsia and maternal cardiovascular risk 
 
  There has been extensive investigation of the long term prognosis of women who develop 
preeclampsia during pregnancy.  This work can provide a model for examining how other 
reproductive exposures, such as low birth weight delivery, may be associated with a woman’s 
long term risk for chronic disease.   
Preeclampsia is a pregnancy disorder characterized by increase in blood pressure and 
proteinuria; eclampsia occurs when seizures are also present. Preeclampsia is a leading cause of 
maternal mortality in the US, and results from a combination of factors including abnormal 
implantation and reduced placental perfusion which then ultimately affects maternal organ 
perfusion.   
11 
 Roberts and Lain have noted that the maternal risk factors for preeclampsia are similar to 
those for CVD:  diabetes, hypertension, obesity, and insulin resistance. [51]  Chesley found that 
women with eclampsia only in the first pregnancy had no increased risk for chronic 
hypertension, [52] but women with recurrent preeclampsia had an excess risk for hypertension 
after 30 years of follow up.  He also found that both primiparous as well as multiparous black 
women with eclampsia had mortality rates 2 to 9 times that of white women, perhaps due to 
higher underlying rates of hypertension among black women.  Sibai found an increased risk for 
chronic hypertension (14.8%) among women with severe preeclampsia compared to women with 
normotensive pregnancies (5.6%). [53]  The differences were particularly profound for women 
who developed preeclampsia prior to 30 weeks gestation (OR 2.3) and those who had recurrent 
preeclamptic pregnancies (OR 7.4).  In addition, women who remained normotensive for all 
pregnancies had the lowest incidence of chronic hyptertension (1.8%). 
These studies demonstrate that when pre-eclampsia occurs early in pregnancy or recurs 
there is an excess risk of future maternal cardiovascular morbidity and mortality.  In addition, 
women with recurrent preeclampsia also have impaired endothelial function [54] and higher 
diastolic blood pressures, smaller-sized low density lipoproteins, increased apolipoprotein B, and 
decreased HDL cholesterol compared with their matched controls. [55] Ness, et al, found that 
women with a family history of cardiovascular disease had an increased risk to develop 
preeclampsia (OR 1.9) and hypertension during pregnancy. [56] These results suggest that 
preeclampsia may be at least in part caused by the same factors that contribute to cardiovascular 
disease later in life.   
Ness and Roberts have suggested that preeclampsia may have two distinct origins, each 
with its own pathologic characteristics and natural history. [57]  One results from reduced 
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 placental perfusion, and another from maternal pre-existing but possibly sub-clinical disorders 
that parallel the risk factors for atherosclerosis and cardiovascular disease.  Women with 
recurring preeclampsia are likely to have underlying risk factors, whereas preeclampsia 
occurring only in first pregnancies may be more related to reduced placental perfusion.  It is 
possible that a similar heterogenous model may be applied to women who deliver a preterm or 
low birth weight infant, such that a preexisting disposition for cardiovascular risk converges with 
other factors to increase the risk for preterm delivery or LBW.  Our study will examine this 
hypothesis in a racially diverse cohort of women, as it is possible that this risk may be different 
in white and black women.   
1.2.3.2. Fetal origins vs. chronic disease model 
 
Due to an ecologic association between high rates of infant mortality and high rates of 
adult ischemic heart disease death in England and Wales, Barker hypothesized in 1986 that 
altered growth in utero, as reflected in lower birth weight, triggers a biologic adaptation to 
nutritional deprivation that predisposes an individual to heart disease, obesity and diabetes. [58]  
Subsequent studies of this fetal origins hypothesis have measured an inverse relationship 
between infant birth weight and adult risk for chronic disease.  This effect has been found 
consistently for blood pressure, with an estimated 2-4 mm Hg lower systolic blood pressure in 
adults for every 1 kg increase in their birth weight. [59] Associations between birth weight and 
adult risk for insulin resistance, type 2 diabetes, [60] and CHD have also been reported. [61] 
Alternatively, or additionally, it is possible that familial aggregation of risk for chronic 
disease, with genetic or environmental components, might explain what has been viewed as the 
effects of in utero undernourishment. [62]  This may be particularly true for developed countries 
where the likelihood of starvation or malnourishment is diminished, and yet rates of LBW, 
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 preterm delivery and cardiovascular disease persist.  It is important to understand the 
mechanisms by which LBW may be associated with long term risk for cardiovascular morbidity 
and mortality.  The fetal origins hypothesis would lead to interventions focused on prenatal and 
childhood nutrition.  In contrast, the chronic disease model would indicate maternal interventions 
to address risk factors for cardiovascular disease such as hypertension, obesity, insulin resistance 
and dyslipidemia.  The current study is designed to describe the long term prognosis of women 
who delivered a LBW infant, and builds on relatively recent research that has found an 
association between delivery of a LBW infant and increased maternal cardiovascular risk. 
1.2.3.3. Common risk factors for low birth weight, preterm delivery and cardiovascular 
disease 
 
The following table summarizes data from multiple studies that identify the risk factors 
for LBW, IUGR and preterm delivery and categorizes those that are commonly associated with 
cardiovascular disease.  Each of these could be a common pathway by which cardiovascular and 
pregnancy risks are elevated.  Similar to the multifactorial model to explain preeclampsia, a 
woman’s underlying risk for chronic disease could affect some of the pathways leading to LBW 
and preterm delivery, in particular those that have been associated with both cardiovascular 
disease and poor pregnancy outcomes. 
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Table 3:  Selected studies of risk factors for low birth weight, preterm delivery and cardiovascular disease in 
women 
Risk factor Low birth weight Growth 
Restriction 
Preterm delivery 
Associated with cardiovascular disease 
 Black race 2.4 (1.9-2.9) [63] 
1.92 (1.64-2.26) a [64] 
2.26 (1.39-3.54) b  [64] 
 
 
2.6 (1.82-3.71) [65] 1.79 (1.55-2.08) [66] 
2.10 (1.33-3.3) [67] 
2.35 (1.72-3.22) c [66] 
 Inflammation/Infection   2.9(1.5-5.5)  d [23] 
3.4 (2.1-5.4)  e [23] 
 Smoking  1.43 (1.22-1.68) f [68] 
2.08 [11] 
2.63 (1.77-3.90) g [68] 
3.18 (2.06-4.91) [65] 
1.24 [11] 
1.24 (1.06-1.44) h [66] 
2.12 (1.55-2.89)  i [66] 
 
 
 Hypertension 1.99 (1.93-2.06) k [69] 
3.58 (3.39-3.79) l [69] 
2.07 (1.35-3.18) [65]  
 Non-gestational 
diabetes 
  3.84 [11] 
 Obesity (BMI >28.8)  1.58 [11]   
 First birth <20   2.91 (1.32-6.45) j [67] 
1.29 (1.05-1.59) k [66] 
Not typically associated with cardiovascular disease 
 Previous preterm 
delivery 
  2.7 (2.1-3.4) [23] 
 Incompetent cervix   6.15 (1.79-21.26) [67] 
 Drug use   3.9 (1.64-9.26) [67] 
Adjusted relative risks or odds ratios (95% CI, when available), [reference] 
a          Black vs. White, low income 
b         Black vs. White,  moderate income 
c          Very preterm (24-32 weeks) vs. term 
d          Fetal fibronectin positive vs. negative, nulliparous women 
e          Fetal fibronectin positive vs. negative, multiparous women 
f          Any vs. none for women age 16-17 
g          Any vs. none for women age 40+ 
h           1+pack/day vs. none and <37 weeks 
i           1+pack/day vs. none and 24-32 weeks 
j           Maternal age < 20 vs. >=20, Black women 
k          Maternal age < 20 vs. >= 20, White women            
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1.2.3.4. LBW and preterm delivery associated with cardiovascular disease risk 
 
There have been five registry-based cohort studies that have detected an association 
between LBW, preterm delivery and cardiovascular mortality.  In 1997 Smith, et al found that 
parents’ overall mortality, as well as cardiovascular mortality, was inversely associated with the 
birth weights of their offspring. [70] Risk for cardiovascular mortality doubled for mothers (95% 
CI 1.18 to3.33) for each kilogram decrease in offspring birth weight; relative risk for fathers was 
1.52 (95% CI 1.03 to 2.17).  The authors concluded that mortality was influenced by factors 
related to birth weight that were transmissible across generations. 
This initial study was replicated in 2000 utilizing a large birth and mortality dataset from 
England and Wales.  Smith, et al [2] found a per kilogram relative risk for cardiovascular 
mortality strikingly similar to that found in the previous study (RR 2.22, 1.46-3.38).  Relative 
risk for cardiovascular mortality after delivering a LBW infant was 7.05 (2.64-18.77).  This 
study was then replicated in a Finnish cohort that also included data on gestational age.  Preterm 
delivery was associated with a hazard ratio of 2.06 (1.22-3.47) for cardiovascular mortality. [4] 
A large cohort study of 676,272 women from Norway designed to determine the long term 
effects of preeclampsia found similar results.  Irgens, et al [3] reported a 2.95-fold increase (95% 
CI 2.12-4.11) in cardiovascular mortality for women who delivered preterm, but without the 
additional complication of preeclampsia (median 13 years after delivery). 
Smith, et al [1] studied 129,920 deliveries and found independent risks for ischemic heart 
disease death or hospitalization with preterm delivery (1.8; 95% CI 1.3-2.5) and LBW (4.3; 95% 
CI 2.9-6.2). Risk for ischemic heart disease death was 11.3 (95% CI 3.5-36.1) for women who 
delivered a LBW infant compared to a normal weight infant. The authors also found that the 
16 
 effects were additive, as women who had infants that were both LBW and preterm had a 3.9-fold 
increase in risk (95% CI 2.2-6.8) of ischemic heart death or hospitalization compared to women 
with normal weight infants born on time. 
Only three studies have related infant birth weight to later occurrence of maternal 
cardiovascular risk factors, but the results have been consistent.  Infant birth weight was 
inversely related to maternal systolic blood pressure [71, 72] and insulin resistance [71], but 
there was no association between infant birth weight and later maternal lipid levels. [70, 71] 
Most of these studies have utilized large data sets of birth data matched to mortality data, and 
therefore have had limited ability to adjust for potential confounders such as smoking status and 
lifetime weight gain.  Only a few have involved vascular and metabolic risk factor data, and 
mean follow up was ten to twenty years.  Our study will build on these findings and potentially 
contribute new information regarding older women with longer follow up, and involve well 
characterized cardiovascular risk measures and disease status. 
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 2. ARTICLE ONE:  ACCURACY AND RELIABILITY OF MATERNAL RECALL 
OF INFANT BIRTH WEIGHT AMONG OLDER WOMEN 
 
2.1. ABSTRACT 
Maternal recall of infant birth weight provides a cost-effective and efficient way to obtain 
pregnancy-related data, and it is often the only source available among older women.  We 
assessed the accuracy and reliability of maternal recall of infant birth weight 35 to 70 years after 
delivery.  Participants were 119 well functioning women (mean age 80 years; 47.5% black) 
randomly selected from participants at the Pittsburgh, Pennsylvania field center of the Study of 
Health, Aging and Body Composition (Health ABC), a prospective study of body composition 
changes and morbidity.  Women were asked via phone to report the birth weight for each 
pregnancy lasting more than six months.  Women who then provided documentation of birth 
weights comprised the validity sample (n=22).  Women who reported birth weights a second 
time in person comprised the reliability sample (n=98).    Women in the validity and reliability 
samples were not different in terms of race, education, income or age at first birth from the 
remaining women in the cohort (n=349) who reported at least one birth.  In the validity sample, 
agreement between recalled and documented birth weights was high for first births (ICC=0.96), 
but lower for higher order births (ICC=0.59).  Recalled birth weights for first births were 
underestimated by 44 g (SD 136 g); higher order births were underestimated by 86g (SD 345 g).  
In the reliability sample, maternal recall was highly reliable for first births (r=0.95) and higher 
order births (r=0.87).  Reliability of recall for first births remained high when considered 
separately by race, education, income and age.  Women report accurate and reliable infant birth 
weight data an average of 57 years after delivery, and recall is particularly precise for first births.   
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2.2. INTRODUCTION 
 
The reproductive history of older women can provide important information to investigate 
relationships between pregnancy exposures and maternal health outcomes. Several studies have 
linked delivery of a low birth weight infant with increased maternal risk for cardiovascular death, 
[1-4] and inter-generational studies have demonstrated that low birth weight, like cardiovascular 
disease, aggregates in families. [5, 6]   
Hospital or state delivery records with documented infant birth weight are often not 
available for deliveries occurring prior to 1950, making retrospective studies involving certain 
reproductive exposures of older women challenging.   Maternal recall of infant birth weight 
provides a cost-effective and efficient way to obtain these data, and it is often the only source 
available.  Previous studies of maternal recall of infant birth weight have focused predominantly 
on the accuracy of short-term recall [7-13], and one study investigated the accuracy and 
reliability of maternal recall of births that occurred, on average, 32 years in the past.[14]  The 
purpose of this study is to assess the accuracy and reliability of maternal recall of infant birth 
weight 35 to 70 years after delivery. 
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2.3. METHODS 
 
2.3.1. Participants 
 
The Health, Aging and Body Composition (Health ABC) Study is a large on-going 
epidemiologic study of how changes in body composition affect morbidity, disability, and 
mortality.  A total of 3,075 community dwelling participants (50% female) were enrolled in 
Pittsburgh, Pennsylvania and Memphis, Tennessee in 1997-1998.  Recruitment procedures have 
been described elsewhere in detail.[15]  Eligibility criteria included: age 70 to 79; self-report of 
no difficulty walking one quarter mile or climbing 10 steps without resting; no difficulty 
performing basic activities of daily living; no use of assistive devices to ambulate; no history of 
active treatment for cancer in the prior three years; and no plans to move out of the area in the 
next three years.  Based on these criteria participants are considered well functioning.[16]  All 
participants signed an informed consent approved by the institutional review board at the 
University of Pittsburgh. 
 
2.3.2. Accuracy and reliability samples 
 
Among 608 women in the Pittsburgh cohort who were interviewed in 2003 and 2004 as part of 
on-going follow-up, we included questions about pregnancy history.  Of the 597 women (98%) 
who provided pregnancy history details, 507 (85%) had at least one live birth.   
24 
 A total of 142 women were randomly selected for clinic visits in addition to phone 
interviews, and these women were first contacted via phone to complete pregnancy history 
questions.  They were then scheduled for a clinic visit and asked to bring documentation of 
infant birth weight in the form of hospital records, birth certificates or other commonly 
maintained family documentation.  Among 119 women (84%) who attended the clinic and 
provided pregnancy data both via phone and in person, 22 (18.5%) provided documentation of at 
least one birth weight.  Evidence provided was reviewed by study personnel and deemed to be 
created at or near the time of delivery.  These 22 women comprised the accuracy sample. 
Birth weights were gathered a second time via recall during the clinic visit from the 
remaining 98 women unable to provide birth weight documentation; an average of two weeks 
elapsed between phone recall and in person recall.  These 98 women comprised the reliability 
sample.   
 
2.3.3. Statistical analysis 
 
Women comprising the accuracy and reliability samples were compared to the remaining cohort 
of women with at least one reported birth weight to ensure that they were representative.  
Characteristics compared were age, race, education, income, smoking status, age at first birth, 
number of live births, and mean infant weight of the first birth.  The chi square test of 
independence and the student t test for independent samples were used to detect differences in 
proportions and means between the groups. 
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 For the accuracy study, we calculated an intraclass correlation coefficient (ICC) between 
the recalled and documented birth weight data.  An ICC greater than 0.8 was considered a strong 
correlation. [17, 18]  An ICC was calculated separately for first births and for higher order births. 
 We also investigated the correspondence between categories of birth weight when 
recalled and documented, as we suspected that women may be able to recall infant birth weight 
more accurately as a categorical vs. continuous variable.  Birth weights were characterized into 
low (<2500 g), normal (2500-3500) and high (>3500 g).  Agreement between classification via 
recall and classification via documentation was evaluated utilizing the kappa statistic.  A kappa 
greater than 0.8 was considered excellent agreement, between 0.61 and 0.8 was considered 
substantial agreement, and between 0.41 and 0.6 was considered moderate agreement.[19]  Since 
a low kappa value may reflect a low prevalence of a trait in the population rather than lack of 
agreement [20], the proportion of positive agreement was also calculated.   
For the recall study, the two reports of maternal recall were compared using Pearson 
correlation coefficients, calculated separately for first versus higher order births.  Correlation 
coefficients were also stratified by race, education, and income.   
 
2.4. RESULTS 
 
A total of 469 women interviewed provided at least one child’s birth weight, collected in 
pounds and ounces and transformed into grams for purposes of analysis.  Mean age at this 
interview was 80, and 47% of women were black.  On average, 56.6 years (SD 5 years) had 
elapsed between delivery of the first birth and age at the time of the interview. 
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 There were no significant differences between women in the accuracy and reliability 
samples in terms of education, income or age at first birth when they were compared to the 
remaining women interviewed (Table 4).  There were slightly more black women in the accuracy 
sample and the women in the accuracy and reliability samples were somewhat less likely to have 
ever smoked. The women in the accuracy and reliability samples were marginally younger than 
the remaining women interviewed (p-value=0.069) and they had more live births (p-
value=0.001).   
 
2.4.1. Accuracy 
 
There were 22 women who provided birth weight documentation for 40 live births; 14 were 
for first births.  Documentation sources included hospital records (50%), baby books with dated 
birth weights (33%), birth certificates (10%) and other sources (7%). Agreement between 
recalled and documented birth weights was very high for first births (ICC=0.96), but lower for 
higher order births (ICC=0.59) (Figure 1).  Agreement between recalled and documented birth 
weights for all births combined was moderate (ICC=0.77).   Recalled weight for first births was 
underestimated on average by 44 g (SD 136 g).  Higher order births were underestimated by 86 
g. (SD 345 g).   
Mothers successfully classified first births into low (<2500 g), normal (2500-3500 g) and 
high (>3500 g) birth weight categories (Kappa=0.83; 95% CI: 0.51-1.00).  Proportion of positive 
agreement was 0.93 for first births.  There was moderate agreement between classification of 
higher order births based on recalled and documented weights (r=0.58, 95% CI: 0.28-0.88).  The 
proportion of positive agreement was 0.81 for higher order births. 
27 
  
2.4.2. Reliability 
 
Among the 98 women who reported birth weights twice via recall, maternal recall of infant 
weight for first births (n=95) was highly reliable (r=0.95).  Correlation between the two instances 
of recall for higher order births (n=227) was 0.87, and overall reliability for all births combined 
was high (r=0.90).  Reliability of recall for first births remained high when considered separately 
by race, education, income and age (Table 5).  Reliability dropped for higher order births across 
all groups, except for the lowest income group.  The correlation coefficient dropped to 0.67 for 
higher order birth weights recalled among women with less than a high school education, but 
remained high (r=0.94) for first births recalled by this group of women.   
 
2.5. DISCUSSION 
 
Our results confirm that women report accurate and reliable infant birth weight data an 
average of 57 years after delivery.  To our knowledge, accuracy and reliability of maternal recall 
of infant birth weight this long after the delivery has not previously been reported.  Our results, 
however, are consistent with those of Tomeo, et al [14] who found that maternal recall of infant 
birth weight an average of 32 years after delivery was valid and reliable.   
Our finding that first births were recalled more accurately than higher order births is also 
consistent with the one other study that examined this aspect of maternal recall.[10]  Previous 
studies reported that women underestimate birth weight on average 25 to 95 g. [8, 10, 14]  Our 
results were remarkably similar to these.   
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 We also confirmed that older women report infant birth weight reliably across race, age 
and socioeconomic strata.  Although women with less than a high school education had less 
consistent recall of higher order births, they were still highly reliable sources of information on 
infant weight for first births. 
Our data confirm the appropriateness of relying on maternal recall of infant birth weight 
in epidemiologic studies, particularly when maternal recall may be the only available source of 
these data.  In a similar study of maternal recall 18 years after delivery, Lumey [11] indicated 
that use of maternal recall data would attenuate the true association between birth weight and 
other outcomes of interest.  His analysis indicated that a 30% increase in sample size would 
compensate for the loss of precision resulting from maternal recall of information about infant 
weights.[11] 
There are limitations to our study.  Our sample of validated birth weights was small.  
Hospital and state records with infant birth weights prior to 1950 are not commonly available in 
Pennsylvania, and this forced us to rely on birth weight records maintained in the home.  We 
found that many women interviewed had given these records to their children or no longer 
maintained them.  Although small, our sample of women with documented infant birth weights 
was representative of our racially diverse cohort according to education, income and age at first 
birth.  Our results, therefore, are generalizable to well functioning community dwelling older 
women.   
Our reliability analysis only tested the consistency of maternal recall of birth weights 
collected two weeks apart, the first report collected by phone and the second report collected in 
person.  Our results, however, were remarkably consistent with another study that reported a 
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 high correlation (r=0.94) between maternal recall of infant birth weight collected two years apart 
among women at a mean age of 78. [14]   
Our results confirm the accuracy and reliability of maternal recall of infant birth weight collected 
on average 57 years after delivery.  Birth weight was recalled with particular precision for first 
births.  Maternal recall is a reliable source of information about infant birth weight for first births 
long after pregnancy, and these data can be valuable for epidemiologic studies linking pregnancy 
history to chronic disease risk among older women, as well as for inter-generational studies of 
low birth weight. 
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Table 4:  Comparison of maternal characteristics (% or mean and SD) for accuracy group, reliability group 
and remaining cohort 
 Accuracy 
(n=22) 
Reliability 
(n=98) 
Remaining Cohort 
(n=349) 
p-Value 
Age 79.4 (2.4) 79.5 (2.5) 80.2 (2.9) 0.069 
Black 54.6% 45.9% 43.6% 0.576 
Education     
 Less than high school 18.2% 12.2% 14.9% 0.356 
 High school graduate 36.4% 41.8% 49.3%  
 Postsecondary 45.5% 45.9% 35.8%  
Family income     
  Less than $10,000 5.0% 8.4% 14.7% 0.188 
  $10,000 to $25,000 40.0% 43.4% 44.7%  
  $25,000 to $50,000 45.0% 30.1% 31.3%  
  $50,000+ 10.0% 18.1% 9.3%  
Ever smoked 31.8% 36.7% 46.4% 0.120 
Age at first birth 22.7 (3.6) 
(range: 16-30) 
23.6 (4.1) 
(range: 16-36) 
23.5 (4.5) 
(range: 14-41) 
0.689 
Number of live births 3.4 (.85) 
(range: 1-5) 
3.5 (1.8) 
(range: 1-10) 
2.9 (1.5) 
(range: 1-9) 
0.001 
First birth (weight in g) 3210 (489) 3211 (543) 3082 (596) 0.111 
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Table 5:  Correlation between recalled infant birth weights stratified by race, education, income and age 
Characteristic 
First births 
(n=95) 
Higher order births 
(n=227) 
Race    
 White 0.953 0.850
 Black 0.957 0.894
Education    
 Less than high 
school 
0.937 0.666
 High school 
graduate 
0.957 0.894
 Postsecondary 0.953 0.916
Family income   
  Less than $10,000 0.918 0.982
  $10,000 to $25,000 0.962 0.848
  $25,000 to $50,000 0.957 0.964
  $50,000+ 0.994 0.956
    
Age    
 Less than 80 0.969 0.845
 80 and older 0.936 0.896
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Figure 1:  Recalled vs. actual infant birth weight, first births vs. higher order births 
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 3. ARTICLE TWO: ASSOCIATION BETWEEN INFANT BIRTH WEIGHT AND 
MATERNAL CARDIOVASCULAR RISK FACTORS IN THE HEALTH, AGING 
AND BODY COMPOSITION STUDY 
 
3.1. ABSTRACT 
 
Mothers who deliver a low birth weight infant may themselves be at excess risk for 
cardiovascular disease.  We investigated whether older women who bore low birth weight 
(LBW) infants had higher blood pressure, lipids, glucose, insulin, interleukin-6, C-reactive 
protein concentrations, and higher pulse wave velocity compared to women with normal weight 
births.  Participants were 446 women (mean age 80 years; 47% black) enrolled in the Pittsburgh, 
PA field center of The Health, Aging and Body Composition Study.  Women reported birth 
weight, smoking status, prematurity, and selected complications for each pregnancy.  Analysis 
was limited to first births not complicated by hypertension or preeclampsia.  Women who had 
delivered a LBW first birth (<2500 g) had a lower current BMI (adjusted for race and age) 
compared to women with normal weight (2500-3500 g) infants (26.6 vs. 28.0 kg/m^2; p=0.057), 
but they had a higher abdominal circumference (98.1 vs. 95.0 cm; p=0.007).  They were also 
more likely to be on anti-hypertensive medication (p=0.061).  After adjustment for BMI, race 
and age, women with a history of a LBW infant had higher levels of IL-6 (p=0.021), fasting 
insulin (p=0.064), and triglycerides (p=0.071), and they were more insulin resistant (p=0.045) 
compared to women with a normal weight infant.  Women who delivered small infants also had 
elevations in systolic blood pressure (p=0.048), and pulse pressures were marginally elevated 
compared to women with a normal weight first birth.  Women who had delivered infants both 
LBW and preterm (<37 weeks) had the smallest babies, had higher current waist circumferences 
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 and systolic blood pressures, and had levels of IL-6, CRP, and insulin resistance that were 
markedly elevated when compared to women with normal weight births.  These findings raise 
the possibility that a history of LBW delivery may identify women who would benefit from 
screening and intervention around risk factors for cardiovascular disease. 
 
3.2. INTRODUCTION 
 
Mothers who deliver a low birth weight infant may themselves be at excess risk for 
cardiovascular disease.  Large registry-based observational studies found that a low birth weight 
delivery increased maternal risk for cardiovascular death 7 to 11-fold [1, 2] and that risk for 
cardiovascular death was 2 to 3 times higher for women who delivered a preterm infant 
compared to those who had delivered an infant at term.[3, 4]  In two studies that related 
reproductive history to later occurrence of cardiovascular risk factors, bearing a low birth weight 
infant was inversely related to systolic blood pressure [5, 6] and maternal insulin resistance.[6] 
Low birth weight (LBW) and its components, idiopathic preterm delivery and intrauterine 
growth restriction (IUGR), share many risk factors with cardiovascular disease (CVD).  These 
include black race [7-10], young maternal age [10, 11], inflammation and infection [12], 
cigarette smoking [10, 11, 13, 14], hypertension [9, 15], and non-gestational diabetes. [13]  It has 
been proposed that unsuccessful adaptation to the profound biologic demands of pregnancy may 
result in growth restriction and perhaps other causes of LBW, and that the reasons for 
maladaptation to pregnancy could involve metabolic and vascular disease pathways.[16]   
Most studies of LBW and CVD to date have utilized large registries of delivery data 
matched to mortality data.  As such, they have had limited ability to adjust for potential 
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 confounders such as life time smoking exposure and weight gain.  Furthermore, they have not 
characterized outcomes beyond ten to twenty years post partum.  We sought to assess the 
association between delivery of a low birth weight infant and increased cardiovascular morbidity 
among older women many.  Specifically, we investigated whether women who bore low birth 
weight infants had later elevations in blood pressure, pulse pressure, lipid profiles, glucose, 
insulin, interleukin-6 (IL-6), C-reactive protein (CRP), and pulse wave velocity. 
 
3.3. METHODS 
 
3.3.1. Participants 
 
The Health, Aging and Body Composition (Health ABC) Study is a large on-going 
epidemiologic study of how changes in body composition affect morbidity, disability, and 
mortality.  A total of 3,075 community dwelling participants (50% female) were enrolled in 
Pittsburgh, Pennsylvania and Memphis, Tennessee in 1997-1998.  Recruitment procedures have 
been described elsewhere in detail.[17]  All participants signed an informed consent approved by 
the institutional review board at the University of Pittsburgh.  Eligibility criteria included:  age 
70 to 79; self-report of no difficulty walking one quarter mile or climbing 10 steps without 
resting; no difficulty performing basic activities of daily living; no use of assistive devices to 
ambulate; no history of active treatment for cancer in the prior three years; and no plans to move 
out of the area in the next three years.  Based on these criteria participants were considered well 
functioning.[18] 
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  Among 608 women in the Pittsburgh cohort who were interviewed in 2003 and 2004 as 
part of the year 7 follow-up visit, we included questions about pregnancy history.  597 women 
(98%) provided pregnancy history details.  Of the 507 (85%) women who had at least one live 
birth, 466 (92%) provided their first born’s birth weight.  Mean age at this interview was 80, and 
47% of women were black.  We excluded women who reported hypertension during pregnancy 
(n=11) or preeclampsia (n=11) to describe maternal prognosis after delivery of a LBW infant 
beyond the well known increase in CVD risk for women with these pregnancy complications. 
[19-24]  Results are presented for 446 women. 
 
3.3.2. Recalled birth characteristics 
 
Women were asked to report the birth weight for each pregnancy lasting more than six 
months.  Smoking status, prematurity (early vs. on time and in weeks) as well as selected 
complications (hypertension during pregnancy and preeclampsia) were also assessed for each 
pregnancy.  Analysis was limited to first births, as birth weight and gestational age are recalled 
more accurately for first births compared to subsequent births.[25]   
 Infant birth weight was converted to grams for the purposes of the analysis, and was 
evaluated as a continuous variable, a dichotomous low birth weight variable (<2500 g vs. 
>=2500 g), and a categorical variable [low (<2500 g), moderate (2500 to 3500 g), and high 
(>3500 g)].  LBW was also stratified by preterm delivery (< 37 weeks gestation).  This 
stratification allowed us to identify a subset of deliveries that were small and preterm. 
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3.3.3. Cardiovascular endpoints 
 
The primary endpoints were cardiovascular risk factors assessed at baseline (1997 to 1998).  
Blood pressures were measured according to standard protocol [26] and pulse pressures were 
calculated (systolic blood pressure minus diastolic blood pressure).  Total cholesterol, HDL, 
triglyercerides, and glucose were assayed from fasting serum with colorimetric technique on a 
Johnson & Johnson Vitros 950 analyzer (New Brunswick, NJ).  Serum insulin (non-diabetics 
only) was determined using a radioimmunoassay kit (Pharmacia, Uppsala, Sweden).  Insulin 
resistance was estimated with the homeostatis model assessment (HOMA), the product of fasting 
glucose and insulin concentrations in mmol/l divided by 22.5.[27]  LDL was estimated with the 
Friedwald equation, and for hemoglobin A1c ion-exchange high performance liquid 
chromatography (Biorad Variant analyzer) was used.  Measures of the inflammatory markers IL-
6, TNF-α, and CRP were obtained from frozen stored serum collected by venipuncture after an 
overnight fast.  Cytokines were measured in duplicate by an enzyme-linked immunosorbent 
essay kit from R&D Systems (Minneapolis, MN).  Serum levels of CRP were also measured in 
duplicate by enzyme-linked immunosorbent essay based on purified protein and polyclonal anti-
CRP antibodies.  Blind duplicate analyses showed an average interassay coefficient of variation 
of 10.3% (IL-6), 8.0% (CRP), and 15.8% (TNF- α). 
 Aortic pulse wave velocity (aPWV) was assessed as an indicator of aortic stiffness and 
was measured from simultaneous Doppler flow signals obtained from the right carotid and right 
femoral arteries by use of nondirectional transcutaneous Doppler flow probes.  At least 10 beats 
were averaged for each simultaneous recording site, and three separate runs were recorded for 
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 each participant.  Timing between the onset of flow at the carotid and femoral sites was divided 
by the associated distance to produce flow velocity.   
 
3.3.4. Statistical analysis 
 
Students t-test or chi-square tests were used to detect differences in means or proportions 
between women who delivered low birth weight vs. normal weight infants.  Characteristics 
compared included sociodemographic status (race, education, and income), pregnancy history 
(smoking status during pregnancy, age at first birth), smoking history [characterized as never, 
former or current and measured in pack years (the average packs of cigarettes smoked daily 
multiplied by years smoking)], presence of diabetes (physician diagnosed and confirmed with 
medication), and current use of statins or anti-hypertensives. 
Pearson correlation coefficients were calculated to compare the relationship between the 
birth weight of the first born and continuous endpoints.  Inflammatory markers, triglycerides, 
glucose, insulin, hemoglobin A1c, and aPWV were log-transformed for the purposes of analysis 
as they were not normally distributed, but results are presented as actual values.  Analysis of 
covariance (ANCOVA) was used to detect differences in the means of body composition 
variables across three birth weight categories (low, moderate and high), adjusted for race and 
age.  These included BMI (kg/m²) at study baseline and at ages 25 and 50 (weight reported via 
recall and height measured at study baseline and adjusted for shrinking [28]); abdominal 
circumference; and visceral fat (estimated with CT scans between fourth and fifth lumbar 
vertebrae).  ANCOVA was also used to detect differences in means (adjusted for BMI, race, and 
age) for each cardiovascular risk factor dichotomized into LBW and normal birth weight groups 
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 as there were no significant differences in these factors for women who delivered infants > 3500 
g.  In secondary analysis current smokers were removed. Moreover, women were stratified by 
race to determine whether the results differed significantly for black and white women.  
Deliveries were also stratified into LBW and preterm versus LBW and not preterm.  All tests 
were two-sided and differences with a p-value <0.05 were considered significant; differences 
<0.1 were considered marginally significant. 
 
3.4. RESULTS 
 
Among the 446 women who recalled the birth weight of their first born (resulting from 
pregnancies not complicated by hypertension or preeclampsia), mean birth weight was 3117 g 
(SD 582), and 56 (12.6%) women recalled having a baby of birth weight less than 2500 g.  
Thirty first births were reported as premature (6.2%).  Average maternal age at first birth was 
23.5 (SD 4.4), and mean number of live births was 3.0 (SD 1.5). 
 Women who delivered a low birth weight infant (<2500 g.) were significantly more likely 
to be black and to have a lower family income compared to women who delivered a normal 
weight infant (>=2500 g., Table 6).  They were also more likely to smoke at some point during 
their lifetimes, to have been younger than age 20 at the time of their first births, and, as expected, 
were more likely to deliver preterm compared to women who delivered a normal weight infant.  
Women who delivered a low birth weight infant were also more likely to be taking anti-
hypertensive medication at the baseline visit (mean age 73) compared to women who delivered a 
normal weight first birth.    
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 In unadjusted analyses of cardiovascular risk factors measured continuously, systolic 
blood pressure showed an inverse association with infant birth weight (r=-0.151, p-value=0.001).  
Diastolic blood pressure showed a similar but weaker association (r=-0.095, p-value=0.041).  
Weight at each of three intervals across a woman’s life time was positively correlated with infant 
birth weight, with correlation coefficients ranging from 0.091 (p-value=0.052) at age 25 to 0.123 
(p-value=0.006) at the baseline visit.  None of the metabolic measures were linearly associated 
with infant birth weight.  CRP was the only inflammatory marker that was significantly (and 
inversely) associated with infant birth weight (r=-0.096, p-value=0.041). 
After adjustment for race and age (Table 7), women who delivered a LBW infant had the 
lowest average BMI at baseline when compared to women with a normal weight infant (26.6 
kg/m² vs. 28.0 kg/m²; p=0.057, but the highest abdominal circumference (98.1 cm v. 95.0 cm; p-
value=0.007). Visceral fat was also higher in this group compared to women with normal weight 
first births (p-value=0.076).   
Women with a prior LBW baby had significantly higher levels of IL-6 compared to 
women with normal weight infants after adjustment for race, age and BMI (p-value=0.021, Table 
8).  CRP demonstrated a similar but weaker trend (p-value=0.059).  Systolic blood pressure was 
elevated in this group of women (p-value=0.048), and pulse pressure was marginally elevated (p-
value=0.069).  For women who delivered LBW versus normal, fasting insulin (p-value=0.064) 
and triglycerides (p-value=0.071) were marginally elevated and these women were more insulin 
resistant (p-value=0.045).  These results did not change when current smokers (n=37) were 
excluded.  Additional adjustment for lifetime cigarette exposure measured in pack years had no 
substantial effect on most estimates with the exception that it attenuated the results for the 
inflammatory markers, but IL-6 (0.794 pg/ml(log) vs. 0.602 pg/ml(log); p-value=0.043) and 
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 CRP (0.887 µg/ml(log) vs. 0.706µg/ml(log); p-value=0.157) remained significantly or 
marginally elevated in women who delivered a LBW infant when compared to women with a 
normal weight infant. 
Considering separately white (n=249) and black women (n=195), those in both groups 
with LBW infants had higher waist circumferences and elevations in systolic blood pressure, 
triglycerides, IL-6, and CRP compared to women with normal weight infants.  The one race-
specific finding related to fasting insulin.  There was no difference in fasting insulin among black 
women who delivered LBW infants when compared to black women with normal weight infants 
(2.17 IU/ml (log) vs 2.11 IU/ml (log); p-value=0.567), and yet fasting insulin was significantly 
elevated in white women with a LBW versus normal birth weight infant (2.10 IU/ml(log) vs. 
1.83 IU/ml (log); p-value=0.016). 
  Despite small numbers (n=18), the sub-group of women who delivered an infant that was 
both preterm and LBW had, on average, the smallest babies and the greatest lifetime cigarette 
smoking exposure (Table 9).  They also had the highest waist circumferences, the highest 
systolic blood pressures and pulse pressures, and the highest levels of CRP, insulin resistance, 
and hemoglobin A1c.  These elevations were significant or marginally significant when 
compared to women with normal weight first births.   
 
3.5. DISCUSSION 
 
Among this group of older women, infant birth weight was inversely related to certain 
inflammatory, metabolic and vascular markers independent of age, race, BMI, and lifetime 
exposure to cigarette smoking.  These associations were present in women up to 60 years post 
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 partum.  These data support a small but emerging body of evidence that LBW pregnancies, in 
particular those complicated by growth restriction or preterm delivery, may involve pathways 
that lead to poor pregnancy outcomes during the reproductive years and higher cardiovascular 
risk later in life.   
Our findings are consistent with those from the only two comparable studies that related 
cardiovascular risk factors to reproductive history.  Fifty years after a LBW first pregnancy, 
Lawlor, et al, reported that systolic blood pressure was elevated and insulin resistance was more 
common. [6]  Walker, et al, also reported an inverse association between maternal systolic blood 
pressure and infant birth weight 19 years after delivery.[5] 
Maternal pre-pregnancy BMI is positively correlated with infant birth weight [29-31], 
and as expected, small women in our study had smaller babies.  However, our results suggest 
that women who delivered a LBW infant had a distinct body composition in older adulthood, 
with low BMI, high waist circumference, and high visceral fat.  The concept of a ‘metabolically 
obese, normal weight’ individual has been described as an individual with  a relative 
preponderance of visceral fat, modest overall weight gain, insulin resistance and greater risk for 
type 2 diabetes.[32-34]  Women who deliver a LBW infant could be at higher risk to develop 
these attributes.  We were unable to determine if these women had higher waist circumferences 
prior to their first birth, although there is evidence that pre-pregnancy waist-hip ratio is positively 
correlated with infant birth weight [30] suggesting that abdominal adiposity in these women with 
small babies may occur post partum.  Interestingly, women in our study with a LBW infant did 
not have higher rates of diabetes. 
Women in our study who delivered a LBW infant were more likely to be on anti-
hypertensive medications, to have higher systolic blood pressures, and to have higher pulse 
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 pressures than women who delivered normal weight infants.  Previous studies have shown that 
women with elevated blood pressure before or during pregnancy, without superimposed 
preeclampsia, have smaller babies and an elevated risk for preterm delivery.[22-24]  In addition, 
small blood pressure elevations during pregnancy in women who remain normotensive have 
been shown to restrict fetal growth.[35]  These results suggest that occult vascular disease could 
lead to pregnancies complicated by placental insufficiency, resulting in restricted fetal growth or 
preterm delivery [22, 36-40], and manifesting later in life as hypertension.   
Inflammatory markers IL-6 and CRP were also elevated in women with a LBW infant, 
suggesting that these women may be predisposed to up-regulation of inflammation that has been 
associated with growth restricted pregnancies [41, 42] and increased CVD risk.[43, 44]  
Alternatively, or additionally, elevated inflammatory markers could reflect the increased central 
adiposity and visceral fat accumulated in these women as they age.[45, 46]  
Women in our study who delivered a LBW infant had higher levels of fasting insulin than 
women with normal or high birth weight infants, they were more insulin resistant, but not more 
likely to be diabetic.  These findings exactly replicate the Lawlor study. [6]  While visceral fat, 
independent of BMI, is a particularly strong marker of insulin resistance in middle-aged[47, 48] 
and elderly adults[49], it may have developed later in adulthood among women with a LBW 
delivery.   This suggestion derives from the observation that diabetes mellitus prior to pregnancy 
does not result in LBW babies [31].  Furthermore, the presence of insulin resistance without 
diabetes mellitus may reflect a recent pathophysiology which has not progressed. 
There are several strengths to our study.  The strong representation of black women in the 
Health ABC cohort made it an ideal population to study, as the rates of LBW and CVD among 
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 black women are almost twice that of white women.[50, 51]  In addition, we were able to 
investigate a variety of cardiovascular risks, and had extensive data on body composition.   
Our study also has limitations.  Because pregnancy history data were collected via recall, 
our results may be imprecise.  Mothers have been found to reliably recall certain pregnancy 
characteristics.  One study confirmed the validity of maternal recall of infant birth weight, 
preterm status, and cigarette smoking when compared to hospital records reflecting actual events 
that occurred, on average, 32 years after delivery.[52]  While it has been demonstrated that 
women recall birth weight with an average underestimate of 25 to 95 g [25, 52, 53], recall is 
most precise for small babies and first births.[25]  That several characteristics of women in our 
study who delivered a LBW infant were consistent with well known attributes associated with 
this outcome (low socioeconomic status, black race, higher rates of smoking, and young maternal 
age) is reassuring.  Nonetheless, assuming the presence of misclassification, it is unlikely that 
women would over or under report infant birth weight systematically based on CVD risk so the 
impact of recall bias would likely be that our observed associations were attenuated.   
Community dwelling, well-functioning women who survive to age 80 with reasonable 
cognitive function are healthier than the general population, thus limiting the generalizability, but 
not the validity, of our findings.  Previous studies identified an association between infant birth 
weight and maternal cardiovascular death in relatively young women. Preexisting CVD was not 
an exclusion criterion for participation in our study, but the impact of survival bias would be to 
underestimate the true magnitude of an effect.  
Our ability to distinguish between preterm and growth restricted LBW infants was 
limited.  Our results suggest that delivery of small, preterm babies is associated with a higher 
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 maternal cardiovascular risk prognosis, as was found in one other study.[3]  This requires further 
investigation in a population where gestational age can be precisely characterized.   
Our results confirm that older women who delivered a first pregnancy complicated by 
LBW had elevations in systolic blood pressure, pulse pressure, IL-6, CRP, and fasting insulin 
compared to women with normal weight infants.  They also had the lowest BMI compared to 
women who delivered normal or high birth weight infants, but the highest abdominal 
circumference and visceral fat content.  Our study provides epidemiologic evidence of an inverse 
association between infant birth weight and maternal risk for cardiovascular disease.  These 
findings need to be replicated and extended, but raise the possibility that sub-clinical maternal 
chronic disease risk may contribute to the persistent public health challenges of LBW and 
preterm delivery.  LBW may mark women who could benefit from screening and intervention to 
delay onset of cardiovascular disease.   
48 
  
Table 6: Maternal Characteristics (% or mean +-SE) according to birth weight of first birth 
  
Low birth weight 
(<2500) 
 (n=56) p Value* 
Normal birth weight
 (>=2500) 
 (n=390) 
Age at Baseline   73.3 ± 0.3 0.477 73.0 ± 0.1 
Black   62.5% 0.003 41.3% 
Education         
  Less than high school 12.5% 0.760 15.4% 
  High school graduate 46.4%   48.0% 
  Postsecondary 41.1%   36.7% 
Family income         
  Less than $10,000 18.9% 0.070 12.1% 
  $10,000 to $25,000 52.8%   42.1% 
  $25,000 to $50,000 17.0%   34.2% 
  $50,000+ 11.3%   11.5% 
Smoking         
  Never 46.4% 0.218 57.7% 
  Former 41.1%   34.6% 
  Current 12.5%   7.7% 
Pack years smoking   19.6 ± 3.5 0.036 12.6 ±1.1 
Smoked during pregnancy   29.1% 0.185 21.2% 
Age at first birth   22.5 ± 0.6 0.065 23.6 ± 0.2 
Younger than 20 at first 
birth 
  30.4% 0.010 16.2% 
Premature delivery (<37 
weeks) 
  32.1% <.0001 2.3% 
Diabetes mellitus   9.1% 0.969 9.3% 
Antihypertensives    64.3% 0.061 50.9% 
Statins   19.6% 0.908 20.3% 
* Chi square or t tests     
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Table 7: Comparison of maternal body composition characteristics according to infant birth weight groups, 
adjusted for race and age 
 
<2500 
(n=56) p Value* 
2500-
3500 
(n=293) 
>3500 
(n=97) p Value* 
Weight (kg)  66.2 0.047 70.2 75.2 0.002 
Height (mm)  1577.7 0.656 1581.8 1598.3 0.022 
BMI, age 25 (kg/m²)  21.8 0.771 22.0 22.1 0.757 
BMI, age 50 (kg/m²)  24.5 0.117 25.3 26.0 0.108 
BMI, study baseline (kg/m²)  26.62 0.057 28.01 29.4 0.021 
Abdominal circumference (cm) ** 98.1 0.007 95.0 96.4 0.138 
Visceral fat (cm²) ** 121.9 0.076 110.4 110.0 0.980 
Abdominal subcutaneous fat (cm²) ** 345.2 0.764 342.5 344.0 0.834 
Total percent fat ** 39.8 0.699 40.0 39.9 0.791 
*Compared to normal birth weight group (2500 g - 3500 g) 
**Adjusted for BMI, race and age at baseline 
Excludes pregnancies complicated by hypertension or preeclampsia 
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Table 8: Comparison of selected maternal characteristics according to delivery of a low birth weight (<2500 
g.)  vs. normal weight (>=2500 g.) infant, adjusted for race, age and BMI 
  Low birth weight 
<2500 
 (n=56) p Value 
Normal birth weight
>=2500  
(n=390) 
Lipids     
 Total cholesterol (mg/dl) 218.5 0.618 220.3 
 HDL (mg/dl) 61.3 0.611 60.2 
 LDL (mg/dl) 128.1 0.726 129.9 
 Triglycerides (mg/dl) 142.0 0.071 126.7 
Vascular     
 Systolic blood pressure 143.1 0.048 137.3 
 Diastolic blood pressure 73.5 0.359 72.2 
 Pulse pressure 69.7 0.069 65.1 
 Pulse wave velocity (cm/sec) 780.6 0.854 772.8 
Metabolic     
 Fasting glucose (mg/dl) 99.2 0.723 97.9 
 Fasting insulin (IU/ml) * 8.1 0.064 7.1 
 Insulin resistance (HOMA score) * 1.9 0.045 1.6 
 Hemoglobin A1C  6.3 0.881 6.2 
Inflammatory    
 IL-6 (pg/ml) 2.3 0.021 1.8 
 TNF-α (pg/ml) 3.0 0.194 3.3 
 CRP (µg/ml) 2.5 0.059 2.0 
* Non-diabetics 
Excludes pregnancies complicated by hypertension or preeclampsia 
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Table 9: Selected maternal characteristics according to preterm delivery status and infant birth weight, 
adjusted for race, BMI and age 
  
Infant 
preterm and 
LBW (<37 
weeks, 
<2500 g) 
(n=18) p Value* 
Infant 
LBW but 
not 
preterm 
(>37 
weeks, 
<2500 g) 
(n=38) p Value* 
Normal 
(>=2500 g) 
(n=390) 
Infant birth weight 1787  2282  3258 
Pack years smoking** 25.4 0.022 16.8 0.297 12.7 
BMI 26.4 0.115 26.7 0.057 28.3 
Waist circumference 99.6 0.026 97.5 0.114 95.3 
Visceral fat  107.88 0.796 129.28 0.014 110.39 
Systolic blood pressure 146.87 0.057 141.51 0.235 137.26 
Pulse pressure 72.36 0.086 68.41 0.263 65.08 
IL-6 (pg/ml) 2.30 0.124 2.24 0.062 1.82 
CRP (µg/ml) 4.01 0.076 2.33 0.243 1.96 
Fasting insulin (IU/ml) 8.24 0.203 8.04 0.141 7.07 
Insulin resistance (HOMA) 1.97 0.112 1.84 0.150 1.60 
Hemoglobin A1C  6.59 0.075 6.09 0.314 6.23 
Triglycerides (mg/dl) 128.5 0.893 148.9 0.031 126.7 
      
* Compared to normal birth weight group (>=2500 g) 
**Unadjusted 
Excludes pregnancies complicated by hypertension or preeclampsia 
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 4. ARTICLE THREE: LOW BIRTH WEIGHT, PRETERM DELIVERY AND 
REMOTE MATERNAL CARDIOVASCULAR RISK: THE HEALTH, AGING AND 
BODY COMPOSITION STUDY 
 
4.1. ABSTRACT 
 
Women who have borne a low birth weight or preterm baby may be at elevated risk for 
later cardiovascular disease.  In a cross sectional study of older women we investigated whether 
delivery of a low birth weight (<2500 g) or preterm (<37 weeks gestation) infant increased 
maternal risk for subclinical or clinical cardiovascular disease.  Participants were 446 women 
(mean age 80 years; 47% black) enrolled in the Pittsburgh, PA field center of The Health, Aging 
and Body Composition Study.  Women reported birth weight, smoking status, prematurity, and 
selected complications for each pregnancy.  Analysis was limited to first births not complicated 
by hypertension or preeclampsia.  After an average follow up of 57 years, women who had 
delivered a low birth weight or preterm infant had a marginally increased risk for clinical 
cardiovascular disease.  After adjustment for well known cardiovascular risk factors, including 
vascular, demographic and lifestyle covariates, women who delivered a preterm infant had a 
2.77-fold increase (95% CI 1.06-7.24) in risk for clinical cardiovascular disease, compared to 
women with infants born on time.  Women who delivered infants that were both early and small 
demonstrated a 4.21-fold increase in risk (95% CI 1.23-14.45).  The increased risk appeared to 
be in women with hypertension suggesting that vascular disease could moderate the relationship 
between infant birth characteristics and maternal cardiovascular disease.  These results need to 
be replicated and expanded, but support an emerging body of evidence that many years after 
having had a small baby, women are at elevated risk for cardiovascular disease. 
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4.2. INTRODUCTION 
 
Women who have borne a low birth weight or preterm baby may be at elevated risk for 
later cardiovascular disease.  Large registry-based observational studies found that a low birth 
weight (LBW) delivery increased maternal risk for cardiovascular death 7 to 11-fold [1, 2] and 
that risk for cardiovascular death was 2 to 3 times higher for women who delivered a preterm 
infant compared to those who delivered an infant at term. [3, 4]  In the few studies to relate 
infant birth weight to later maternal cardiovascular risk factors, bearing a low birth weight infant 
was inversely related to maternal systolic blood pressure [5, 6] and insulin resistance [6], but had 
no association with maternal lipid levels. [6, 7]    
Underlying risk for cardiovascular disease may affect a woman’s ability to successfully 
adapt to the vascular or metabolic demands of pregnancy, leading to poor pregnancy outcomes 
during the reproductive years and higher cardiovascular risk later in life. [8] There is evidence 
that even small elevations in maternal blood pressure during pregnancy that remain within the 
‘normal’ range can restrict fetal growth [9], and placental vascular lesions have been associated 
with fetal growth restriction [10] and preterm delivery. [11]  In addition, infection or 
inflammation has been implicated in preterm birth [11-13], fetal growth restriction [13, 14], as 
well as cardiovascular disease risk among women. [15]   
In a cross sectional study of older women we investigated the relationship between 
recalled pregnancy characteristics and cardiovascular disease status.  Specifically, we examined 
whether women who reported they had borne small (< 2500 g) or preterm (< 37 weeks gestation) 
infants had an increased risk for clinical or subclinical cardiovascular disease.  We also sought to 
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 assess whether vascular, metabolic, body composition or inflammatory measures may mediate 
this risk. 
 
4.3. METHODS 
 
4.3.1. Participants 
 
The Health, Aging and Body Composition (Health ABC) Study is a large on-going 
epidemiologic study of how changes in body composition affect morbidity, disability, and 
mortality.  A total of 3,075 community dwelling participants (50% female) were enrolled in 
Pittsburgh, Pennsylvania and Memphis, Tennessee in 1997-1998.  Recruitment procedures have 
been described elsewhere in detail.[16]  All participants signed an informed consent approved by 
the institutional review board at the University of Pittsburgh.  Eligibility criteria included:  age 
70 to 79; self-report of no difficulty walking one quarter mile or climbing 10 steps without 
resting; no difficulty performing basic activities of daily living; no use of assistive devices to 
ambulate; no history of active treatment for cancer in the prior three years; and no plans to move 
out of the area in the next three years.  Based on these criteria participants were considered well 
functioning.[17] 
 Among 608 women in the Pittsburgh cohort who were interviewed in 2003 and 2004 as 
part of the year 7 follow-up visit, we included questions about pregnancy history.  597 women 
(98%) provided pregnancy history details.  Of the 507 (85%) women who had at least one live 
birth, 466 (92%) provided their first born’s birth weight.  Mean age at this interview was 80, and 
47% of women were black.  We excluded women who reported hypertension during pregnancy 
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 (n=11) or preeclampsia (n=11) to describe maternal prognosis after delivery of a LBW infant 
beyond the well known increase in cardiovascular risk for women with these pregnancy 
complications. [18-23]   Our analysis was based on the recalled birth characteristics of 446 
women and their updated cardiovascular disease status (prevalent and incident) at year 7 of 
follow up.   
 
4.3.2. Recalled birth characteristics 
 
Women were asked to report the birth weight for each pregnancy lasting more than six 
months.  Smoking status, prematurity (early vs. on time and in weeks) as well as selected 
complications (hypertension during pregnancy and preeclampsia) were also assessed for each 
pregnancy.  Analysis was limited to first births, as birth weight and gestational age are recalled 
more accurately for first births compared to subsequent births.[24]   
 Infant birth weight was converted to grams for the purposes of the analysis, and was 
evaluated as a continuous variable and a dichotomous low birth weight variable (<2500 g vs. 
>=2500 g).  Infants reported as being born early (< 37 weeks gestation) were considered preterm.  
LBW was stratified by preterm delivery to identify a subset of deliveries that were small and 
premature. 
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4.3.3. Cardiovascular disease endpoints 
 
We categorized participants into three cardiovascular disease groups:  those with clinical 
cardiovascular disease, those with subclinical cardiovascular disease, and those with no clinical 
or subclinical cardiovascular disease.   
Participants with clinical cardiovascular disease included those with prevalent disease 
and those with incident events.  Prevalent cardiovascular disease was ascertained at baseline 
(1997 to 1998) via self-report and was validated with algorithms that included selected 
medications and ECG results.  These disease algorithms were developed by the Health ABC 
investigators to mirror the adjudicated diagnoses in the Cardiovascular Health Study. [25]  There 
were 101 participants with the following prevalent conditions: myocardial infarction, angina, 
coronary artery bypass surgery, or percutaneous transluminal angioplasty (70 participants); ECG 
evidence of myocardial infarction (3 participants); stroke (22 participants); or peripheral vascular 
disease (6 participants).  Incident events that occurred after baseline were ascertained by phone 
contact or at the clinic examination every six months (1998 to 2002), validated by medical record 
review, and adjudicated by committee. [26]  Among 31 participants with incident cardiovascular 
events, 30 had a myocardial infarction or angina and 1 had a stroke.  Overall, 132 women 
(29.6%) were identified with clinical cardiovascular disease. 
Participants with prevalent subclinical cardiovascular disease were categorized according 
to previously published protocol [27-29] on the basis of a finding of one of the following 
assessed at baseline: positive results on the Rose questionnaire for angina (9 participants); 
intermittent claudication (10 participants); an ankle-brachial index <0.9 (15 participants); or the 
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 presence of electrocardiographic abnormalities (70 participants).  Ankle-brachial index was the 
ratio of the mean of two resting measurements of systolic blood pressure in the right arm and 
both legs using an 8-MHz Doppler stethoscope.  The lowest ankle-brachial index of either leg 
was used.  Electrocardiographic abnormalities were detected by a 12-lead electrocardiogram 
using a standardized protocol, and all data were acquired using the Marquette Electronic MAC 
PC Resting ECG Analysis System (Marquette Electronics Inc., Milwaukee, Wisconsin).  Clinical 
physicians examined all abnormal cardiograms, and all ECG data were transmitted daily to the 
core electrocardiographic lab, where the quality of the ECG was assessed and the interpretation 
confirmed.  ECG abnormalities considered as evidence of subclinical disease included: atrial 
fibrillation; long PR interval; short PR interval; ST- or T-wave abnormalities; left bundle branch 
block; right bundle branch block; intraventricular block; left anterior hemiblock; left anterior 
hemiblock with right bundle branch block; and incomplete left bundle branch block.  Overall, 
104 women (23.3%) were categorized as having subclinical cardiovascular disease. 
The remaining 210 participants (47.1%) without evidence of clinical or subclinical 
cardiovascular disease comprised the group with no cardiovascular disease. 
 
4.3.4. Covariates 
 
Covariates included characteristics with an established association with LBW or 
cardiovascular disease.  Sociodemographic and lifestyle variables included age, race, education, 
income, and smoking status (characterized as never, former, current; and measured in pack years 
[the average packs of cigarettes smoked daily multiplied by years smoking]). Participants 
reported annual family income at study baseline, and also described how well their income fit 
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 their needs (poorly, fairly well, very well).  Due to the high number of missing values for family 
income (n=63, 14%), a low socioeconomic indicator variable was calculated for women who 
reported either the lowest quartile of family income or the lowest level of income adequacy.   
Dichotomous disease covariates included adjudicated presence of diabetes mellitus (self-
report and medication), hypertension (self report and medication, or systolic blood pressure 
above 135 and diastolic blood pressure above 85), and metabolic syndrome (NCEP III definition 
[30] as three or more of the following: abdominal circumference > 88; blood pressure >=130/85 
or taking anti-hypertensive medication; fasting glucose >= 110 or taking insulin or oral 
antidiabetic agents; HDL cholesterol < 50; or triglycerides >= 150).  Body composition 
covariates included BMI (kg/m²), abdominal circumference, and visceral fat (estimated with CT 
scans between fourth and fifth lumbar vertebrae).   
Additional covariates included: systolic and diastolic blood pressures measured according 
to standard protocol [25]; pulse pressures (systolic minus diastolic blood pressure); pulse wave 
velocity (measured from simultaneous Doppler flow signals obtained from the right carotid and 
right femoral arteries by use of nondirectional transcutaneous Doppler flow probes); total 
cholesterol, high-density lipoprotein cholesterol, and triglycerides (all measured on fasting serum 
by a colorimetric technique on a Johnson and Johnson Vitros 950 analyzer, New Brunswick, NJ); 
serum insulin (non-diabetics only) and glucose (determined using a radioimmunoassay kit 
[Pharmacia, Uppsala, Sweden]; insulin resistance (estimated with the homeostasis model 
assessment: the product of fasting glucose and insulin concentrations in mmol/l divided by 22.5) 
[31]; low-density lipoprotein cholesterol (estimated with the Fiedwald equation); hemoglobin 
A1c (via ion-exchange high performance liquid chromatography (Biorad Variant analyzer); and 
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 IL-6 and CRP (measured in duplicate from overnight fasting serum by an enzyme-linked 
immunosorbent essay kit from R&D Systems [Minneapolis, MN]). 
 
4.3.5. Statistical analysis 
 
Differences in means and proportions of covariates were assessed across the three 
cardiovascular disease groups using analysis of variance and chi square tests.  Analysis of 
covariance was used to detect more precise differences in means for body composition variables 
(adjusted for race and age) and vascular, metabolic and inflammatory measures (adjusted for 
race, age and BMI).  Inflammatory markers, triglycerides, glucose, insulin, hemoglobin A1c, and 
aPWV were log-transformed for the purposes of analysis as they were not normally distributed, 
but results are presented as actual values.  Simple logistic regression was used to assess the 
association between a woman’s subclinical or clinical cardiovascular disease risk and infant 
characteristics:  birth weight (as a continuous variable measured in kilograms), LBW, preterm 
status, and the combined effect of delivering an infant both LBW and preterm.  The referent 
group was women with no cardiovascular disease.  Multivariate logistic regression models were 
built to assess the independent association between infant characteristics and clinical 
cardiovascular disease, as there were no univariate associations between any birth outcomes and 
subclinical cardiovascular disease.  The models were adjusted for age, race, low socioeconomic 
status, young maternal age, and the lipid covariates (HDL cholesterol and use of statins) that had 
a univariate relationship with clinical cardiovascular disease, as maternal lipid levels did not 
differ based on infant birth weight.  These adjusted models were then separately adjusted for 
body composition (BMI, visceral fat, abdominal circumference), inflammatory (IL-6 and CRP), 
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 vascular (systolic and diastolic blood pressures, PWV, hypertension), and metabolic (glucose, 
triglycerides, diabetes) covariates to identify pathways that may moderate or mediate an 
association between infant birth weight, prematurity and cardiovascular disease.  Tests for 
interaction were done if risk estimates appeared to be altered.  All tests were two-sided, and 
differences with a p-value <0.05 were considered significant; differences with a p-value <0.1 
were considered marginally significant. 
 
4.4. RESULTS 
 
Among the 446 women who recalled the birth weight of their first born, mean birth 
weight was 3117 g (SD 582), and 56 (12.6%) women reported having a baby of birth weight less 
than 2500 g.  Thirty first births were reported as premature (6.2%); 18 of these were also LBW.  
Average maternal age at first birth was 23.5 (SD 4.4), and mean number of live births was 3.0 
(SD 1.5).   
 Women with subclinical and clinical cardiovascular disease were marginally older than 
women free from disease (Table 10).  Women with clinical cardiovascular disease were more 
likely to be black and somewhat more likely to report low socioeconomic status compared to 
women with no disease.  Women with subclinical cardiovascular disease had higher levels of 
education and were less likely to be of low socioeconomic status compared to women with no 
disease.  Women with subclinical cardiovascular disease were combined with the group with no 
disease for subsequent analysis, as the two groups had similar rates of LBW and premature 
deliveries. 
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 Women with clinical cardiovascular disease vs. none (no disease and subclinical, n=314) 
were more likely to have diabetes mellitus (p=0.001), to have lower levels of HDL (p-
value=0.044), and to have higher levels of fasting glucose (p=0.006, Table 11).  Women with 
clinical cardiovascular disease were more also more likely to use anti-hypertensive medication 
(p<0.0001) and statins (p=0.002) compared to women with no cardiovascular disease, and they 
were somehwhat more likely to have hypertension.  The two groups of women had similar BMIs, 
but the group with clinical cardiovascular disease had somewhat elevated levels of visceral fat, 
although this difference was not significant. 
Women with clinical cardiovascular disease vs. none were more likely to have been 
younger than age 20 at the time of their first births (p=0.012), and they had moderately higher 
rates of low birth weight (p=0.089) or preterm delivery (p=0.081).    
 Delivery of a low birth weight vs. normal weight infant was associated with a modestly 
increased risk for clinical cardiovascular disease (OR 1.63, 95% CI 0.87 to 3.05, Table 12).  
Delivery of a preterm vs. term infant produced an unadjusted risk for clinical cardiovascular 
disease of 1.65 (95% CI 0.72 to 3.79) and delivery of an infant both LBW and preterm produced 
a risk of 2.19 (95% CI 0.79 to 6.04).  Risk for cardiovascular disease modestly decreased for 
each additional kilogram in infant birth weight (OR 0.80, 95% CI 0.56 to 1.15).  After 
adjustment for age, race, young maternal age, low socioeconomic status, HDL cholesterol and 
use of statins, women who reported that their infant was born premature vs. on time had a 
modestly elevated 1.93-fold increase in risk of clinical cardiovascular disease (95% CI .79 to 
4.72).  Risk for cardiovascular disease was 2.50 times higher (95% CI .83 to 7.55) for women 
with infants that were both small and early compared to women with normal weight infants born 
on time.   
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  After additional adjustment for the vascular covariates (hypertension, pulse wave 
velocity, and systolic blood pressure), women who had delivered preterm infants had a 
statistically significant 2.77-fold increase in risk for cardiovascular disease (95% CI 1.06 to 7.24) 
when compared to women with term infants (Table 13).  Those with babies born both small and 
early (versus babies born normal weight and on time) had a four-fold increase in risk for clinical 
cardiovascular disease (OR 4.21 95% CI 1.23 to 14.45). Addition of body composition, 
inflammatory, and metabolic measures did not appear to alter the risk estimates of infant birth 
characteristics associated with clinical cardiovascular disease. 
 The additional adjustment of vascular measures in our model increased the risk estimates 
for preterm delivery, suggesting interaction.  The interaction of preterm delivery and 
hypertension was not significant (p=0.267), however, likely due to small numbers.  When we 
stratified our adjusted model by presence of hypertension, women with a preterm delivery had a 
4.99-fold (95% CI 1.35 to 18.54) increase in clinical cardiovascular disease.  In women without 
hypertension, risk of clinical cardiovascular disease associated with a preterm delivery was 
reduced to 1.44 (95% CI .23 to 9.00).   
 
4.5. DISCUSSION 
 
Among this group of older women, those who delivered an infant that was LBW or 
preterm showed an increased risk, albeit marginally significant, of clinical cardiovascular 
disease.  This association was detected with an average follow up of 57 years after delivery and 
after excluding pregnancies complicated by preeclampsia or hypertension.  After adjustment for 
well known cardiovascular risk factors, including vascular covariates, women who delivered a 
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 preterm infant had a 2.77-fold increase in risk for clinical cardiovascular disease, compared to 
women with infants born on time.  Women who delivered infants that were both early and small 
demonstrated a 4.21-fold increase in clinical cardiovascular disease risk.  The increased risk 
appeared to be in women with hypertension, suggesting that vascular disease could moderate the 
relationship between infant birth characteristics and maternal cardiovascular disease.  These 
results support an emerging body of evidence that many years after having had a small baby, 
women are at elevated risk for cardiovascular disease. 
 Our study is the first, to our knowledge, to investigate the association between LBW or 
preterm delivery and maternal cardiovascular morbidity in a population of older women, 
adjusted for a variety of sociodemographic, physical, and biologic correlates of cardiovascular 
disease.  Large registry-based observational studies, with limited ability to adjust for 
confounding, found an increased risk for maternal cardiovascular death in relatively young 
women following a low birth weight [2, 7] or preterm delivery. [3, 4]  Our findings among older 
women are remarkably consistent with the only other study to examine the combined endpoint of 
maternal cardiovascular hospitalization or death following the delivery of a LBW or preterm 
infant.  Smith, et al, found a 4-fold increase in risk for ischemic heart disease among women who 
delivered an infant both LBW and preterm 15 to 19 years in the past. [1]  
 Infant birth weight has been found to be inversely related to maternal systolic blood 
pressure measured in women aged 34 to 79. [5, 6]  Women in our study with clinical 
cardiovascular disease had high levels of hypertension and elevated pulse wave velocities, a 
marker of arterial stiffness.  When adjusted for both of these factors, women who delivered a 
preterm infant had almost three times the risk for clinical cardiovascular disease compared to 
women who delivered infants at term.  Although small numbers limited our ability to find 
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 significant interaction, the increased risk of cardiovascular disease associated with preterm 
delivery was primarily observed in women with hypertension, suggesting that vascular disease 
may moderate this association.   
Previous studies have shown that women with elevated blood pressure before or during 
pregnancy, without superimposed preeclampsia, have smaller babies and an elevated risk for 
preterm delivery. [21-23]  Even small blood pressure elevations within the ‘normal’ range in 
pregnant women who remain normotensive have been shown to be associated with restricted 
fetal growth. [9, 32]  In addition, maternal decidual or myometrial vascular changes have been 
associated with intrauterine growth restriction [10] and preterm delivery [11] in pregnancies not 
complicated by preeclampsia or hypertension.  These findings suggest that occult maternal 
vascular disease may contribute to fetal growth restriction and preterm delivery, and over the 
course of a woman’s lifetime could lead to hypertension or arterial stiffness that ultimately 
increases risk for cardiovascular disease.  
We found no association between infant birth weight or preterm delivery and subclinical 
cardiovascular disease.  We may have had limited power to detect what are likely to be more 
subtle associations.  Alternatively, women in our study with subclinical disease may have been 
healthier or been better clinically managed than those who had progressed to clinical 
cardiovascular disease by age 80.  That they were better educated, had a higher socioeconomic 
status, and had similar rates of preterm and LBW delivery compared to women with no 
cardiovascular disease suggests this may be the case. 
There are several strengths to our study.  The strong representation of black women in the 
Health ABC cohort made it an ideal population to study, as the rates of LBW [33, 34], preterm 
delivery [35, 36], and cardiovascular disease [37] among black women are about twice that of 
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 white women. We were able to describe both clinical and subclinical cardiovascular disease, and 
were able to include extensive physical and biologic covariates associated with LBW, preterm 
delivery and cardiovascular disease.   
Several limitations of our study may affect the interpretation of our results.  Our work 
should be considered preliminary, as many of our estimates were imprecise.  Because pregnancy 
data were collected via recall, our exposure variables are subject to missclassification.  Mothers 
have been found to reliably recall certain pregnancy characteristics.  One study confirmed the 
validity of maternal recall of infant birth weight, preterm status, and cigarette smoking when 
compared to hospital records reflecting actual events that occurred, on average, 32 years after 
delivery. [38]  While it has been demonstrated that women recall birth weight with an average 
underestimate of 25 g to 95 g [24, 38, 39], recall is most precise for first births and small babies. 
[24]  Nonetheless, assuming the presence of misclassification, it is unlikely that women would 
systematically over or under report infant birth weight or preterm status based on cardiovascular 
disease risk so the impact of recall bias would likely be that our observed associations were 
attenuated. 
Community dwelling, well-functioning women who survive to age 80 with reasonable 
cognitive function are healthier than the general population, thus limiting the generalizability, but 
not the validity, of our findings.  Preexisting cardiovascular disease was not an exclusion 
criterion for participation in our study, but the impact of survival bias would be to underestimate 
the true magnitude of an effect. 
Our ability to distinguish between preterm and growth restricted LBW infants was 
limited.  Our results suggest that delivery of small, preterm babies was associated with a higher 
maternal cardiovascular disease risk, but this should be confirmed in a population where infant 
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 characteristics can be precisely characterized.  In addition, we may have underestimated 
preeclampsia or hypertension during pregnancy due to imprecise maternal recall.  Additional 
studies where these pregnancy complications can be better characterized are needed to validate 
our findings. 
Our results suggest that older women who delivered a small or preterm first birth had an 
increased risk for clinical cardiovascular disease after adjusting for demographics, smoking, and 
comorbidities.  This was particularly true in women with hypertension or arterial stiffness, 
suggesting an interaction with maternal vascular disease.  
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Table 10: Selected maternal characteristics (% or mean and SE) according to cardiovascular disease status 
  
No CVD 
(n=210) 
Subclinical 
CVD (n=104) p Value* 
Clinical 
CVD 
(n=132) p Value** 
Sociodemographic and Lifestyle 
  Age at Baseline 72.8 ± .19 73.3 ± .28 0.159 73.2 ± .24 0.196 
  Black 37.14% 40.38% 0.578 57.58% 0.000 
  Education           
     Less than high school 16.67% 8.65% 0.046 17.42% 0.932 
     High school graduate 45.24% 58.65%   43.18%   
     Postsecondary 38.10% 32.82%   39.39%   
  Low socioeconomic status 14.76% 10.58% 0.305 18.94% 0.310 
  Ever smoked (former or current) 40.0% 44.2% 0.474 49.2% 0.093 
  Pack years smoked 11.1 ± 1.5 12.21 ± 2.3 0.688 18.4 ± 2.0 0.005 
Pregnancy 
  Infant birth weight (g) 3153 ± 40 3103 ± 57 0.479 3071 ± 51 0.213 
  Low birth weight infant (<2500 g) 10.95% 10.58% 0.920 16.67% 0.128 
  Premature delivery (<37 weeks) 5.71% 2.88% 0.269 9.09% 0.234 
  Smoked during pregnancy 20.57% 24.75% 0.405 22.66% 0.651 
  Age at first birth 23.5 ± .3 23.7 ± .4 0.797 23.4 ± .4 0.746 
  Younger than age 20 at first birth 15.24% 14.56% 0.875 25.00% 0.025 
* Women with subclinical CVD compared to women with no CVD 
**Women with clinical CVD compared to women with no CVD 
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Table 11: Maternal characteristics according to clinical cardiovascular disease vs. none (adjusted for race, 
age and BMI) 
  
No CVD 
(n=314) 
Clinical 
CVD 
(n=132) p Value 
Body Composition    
 BMI, age 73 (kg/m²) 28.2 28.0 0.805 
 Visceral fat (cm²) 110.0 116.1 0.175 
Lipids     
 HDL (mg/dl) 61.4 57.9 0.044 
  Statins 16.3% 29.6% 0.002 
Vascular     
  Hypertension 58.6% 68.2% 0.058 
  Antihypertensives  45.1% 70.5% <.0001 
 Systolic blood pressure 138.5 136.9 0.465 
  Pulse wave velocity (cm/sec) 757.5 810.8 0.136 
Metabolic     
  Fasting glucose (mg/dl) 96.3 102.4 0.006 
  Fasting insulin (IU/ml) 7.0 7.65 0.088 
 Diabetes mellitus 6.4% 16.0% 0.001 
  Metabolic syndrome 39.4% 43.2% 0.461 
Inflammatory     
  IL-6 (pg/ml) 1.91 1.79 0.363 
 CRP (µg/ml) 2.06 1.94 0.446 
Pregnancy     
  Infant birth weight (g) 3079 ± 28 2947 ± 63 0.287 
  Low birth weight infant (<2500 g) 10.8% 16.7% 0.089 
  Premature delivery (<37 weeks) 4.8% 9.1% 0.081 
  Smoked during pregnany 21.9% 22.7% 0.869 
  Age at first birth 23.0 ± .2 22.5 ± .4 0.879 
  Younger than age 20 at first birth 15.0% 25.0% 0.012 
 
72 
  
Table 12: Crude and multivariate assessment of clinical cardiovascular disease risk and infant birth 
characteristics 
  Clinical Cardiovascular Disease 
  Crude OR (CI) 
p 
Value Adjusted OR (CI)* p Value 
Infant birth weight (kg) 0.80 (.56, 1.15) 0.229 .85 (.58-1.24) 0.397 
Low birth weight (<2500 g) 1.63 (.87, 3.05) 0.131 1.30 (.66, 2.56) 0.449 
Preterm (<37 weeks) 1.65 (.72, 3.79) 0.238 1.93 (.79, 4.72) 0.151 
Low birth weight and Preterm** 2.19 (.79, 6.04) 0.131 2.50 (.83, 7.55) 0.104 
     
*Adjusted for age, race, HDL cholesterol, smoking, low SES, maternal age <20, statin use 
**Reference group are women with infants normal birth weight (>=2500 g) and not preterm 
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Table 13: Multivariate assessment of clinical cardiovascular disease risk and infant birth characteristics 
(adjustment for body composition, inflammatory, vascular and metabolic measures) 
  Body Composition* Inflammatory Markers** 
  Adjusted OR (CI)* p Value Adjusted OR (CI)* p Value 
Infant birth weight (kg) 0.83 (.56, 1.22) 0.339 .87 (.59, 1.30) 0.503 
Low birth weight (<2500 g) 1.37 (.68, 2.75) 0.376 1.17 (.58, 2.36) 0.655 
Preterm (<37 weeks) 1.96 (.79, 4.82) 0.146 2.01 (.81, 4.98) 0.132 
Low birth weight and Preterm 2.64 (.86, 8.12) 0.091 2.49 (.82, 7.59) 0.108 
     
 Vascular measures† Metabolic measures ‡ 
 Adjusted OR (CI)* p Value Adjusted OR (CI)* p Value 
Infant birth weight (kg) .78 (.52, 1.17) 0.230 0.85 (.57, 1.25) 0.402 
Low birth weight (<2500 g) 1.44 (.71, 2.93) 0.313 1.29 (.65, 2.60) 0.468 
Preterm (<37 weeks) 2.77 (1.06, 7.24) 0.037 1.84 (.73, 4.66) 0.199 
Low birth weight and Preterm 4.21 (1.23-14.45) 0.022 2.21 (.70, 6.96) 0.199 
     
All models adjusted for age, race, HDL cholesterol, smoking, low SES, maternal age <20, statin use 
* BMI, visceral fat (log), abdominal circumference added to model 
** Il-6 (log), CRP (log) added to model 
† Systolic blood pressure, diastolic blood pressure, PWV (log) and hypertension added to model 
‡ Glucose (log), diabetes, triglycerides (log) added to model 
 
74 
 4.6. LITERATURE CITED 
 
1. Smith, G., J. Pell, and D. Walsh, Pregnancy complications and maternal risk of 
ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet, 2001. 
357(9273): p. 2002-6. 
2. Davey Smith, G., S. Harding, and M. Rosato, Relation between infants' birth weight and 
mothers' mortality: prospective observational study. BMJ, 2000. 320(7238): p. 839-40. 
3. Irgens, H., et al., Long term mortality of mothers and fathers after pre-eclampsia: 
population based cohort. BMJ, 2001. 323(7323): p. 1213-17. 
4. Davey Smith, G., et al., Birth dimensions of offspring, premature birth, and the mortality 
of mothers. Lancet, 2000. 356: p. 2066-67. 
5. Walker, B., et al., Contribution of parental blood pressures to association between low 
birth weight and adult high blood pressure: cross sectional study. BMJ, 1998. 316: p. 
834-7. 
6. Lawlor, D., G. Davey Smith, and S. Ebrahim, Birth weight of offspring and insulin 
resistance in late adulthood: cross sectional survey. BMJ, 2002. 325: p. 359-62. 
7. Davey Smith, G., et al., Birth weight of offspring and mortality in the Renfrew and 
Paisley study: prospective observational study. BMJ, 1997. 315(717): p. 1189-1193. 
8. Sattar, I. and I. Greer, Pregnancy complications and maternal cardiovascular risk: 
opportunities for intervention and screening? BMJ, 2002. 325: p. 157-160. 
9. Churchill, D., I. Perry, and M. Beevers, Ambulatory blood pressure in pregnancy and 
fetal growth. Lancet, 1997. 349: p. 7-10. 
10. Sheppard, B. and J. Bonnar, The ultrastructure of the arterial supply of the human 
placenta in pregnancy complicated by fetal growth restriction. Br J Obstet Gynaecol, 
1976. 83: p. 948-59. 
11. Germain, A., et al., Preterm labor: placental pathology and clinical correlation. 
Obstetrics and Gynecology, 1999. 94(284-289). 
12. Goldenberg, R., J. Iams, and B. Mercer, The preterm prediction study: the value of new 
vs. standard risk factors. American Journal of Public Health, 1998. 88(2): p. 233-8. 
13. Silver, R., B. Schwinzer, and J. McGregor, Interleukin-6 levels in amniotic fluid in 
normal and abnormal pregnancies: preeclampsia, small for gestational age fetuses, and 
preterm labor. Am J Obstet Gynecol, 1993. 169(5): p. 1101-5. 
14. Bartha, J., R. Romero-Carmona, and R. Comino-Delgado, Inflammatory cytokines in 
intrauterine growth retardation. Acta Obstet Gynecol Scand, 2003. 82: p. 1099-102. 
15. Ridker, P., et al., C-reactive protein and other markers of inflammation in the prediction 
of cardiovascular disease in women. NEJM, 2000. 342(12): p. 836-43. 
16. Visser, M., et al., Leg muscle mass and composition in relation to lower extremity 
performance in men and women aged 70 to 79: the Health, Aging and Body Composition 
Study. JAGS, 2002. 50(5): p. 897-904. 
17. Rooks, R., et al., The association of race and socioeconomic status with cardiovascular 
disease indicators among older adults in the Health, Aging, and Body Composition 
Study. Journal of Gerontology: Social Sciences, 2002. 57B(4): p. S247-S256. 
18. Roberts, J. and K. Lain, Recent insights into the pathogenesis of pre-eclampsia. Placenta, 
2002. 23: p. 359-372. 
75 
 19. Chesley, L., J. Annitto, and R. Cosgrove, The remote prognosis of eclamptic women: 
sixth periodic report. Am J Obstet Gynecol, 1976. 124: p. 446-59. 
20. Sibai, B., A. El-Nazer, and A. Gonzalez-Ruiz, Severe preeclampsia in young primigravid 
women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol, 
1986. 155: p. 1011-6. 
21. Ananth, C., A. Peedicayil, and D. Savitz, Effect of hyptertensive diseases in pregnancy on 
birthweight, gestational duration, and small-for-gestational age births. Epidemiology, 
1995. 6: p. 391-395. 
22. Haelterman, E., et al., Effect of uncomplicated chronic hypertension on the risk of small-
for-gestational age birth. American Journal of Epidemiology, 1997. 145(8): p. 689-695. 
23. Waugh, J., et al., Birth weight and 24-hour ambulatory blood pressure in nonproteinuric 
hypertensive pregnancy. Am J Obstet Gynecol, 2000. 183(3): p. 633-637. 
24. Seidman, D., et al., Accuracy of mothers' recall of birthweight and gestational age. 
British Journal of Obstetrics and Gynaecology, 1987. 94(8): p. 731-5. 
25. Fried, L., et al., The Cardiovascular Health Study: design and rationale. Annals of 
Epidmiology, 1991. 1(3): p. 263-276. 
26. Ives, D., A. Fitzpatrick, and D. Bild, Surveillance and ascertainment of cardiovascular 
events: the Cardiovascular Health Study. Annals of Epidmiology, 1995. 5: p. 278-285. 
27. Kuller, L., et al., Subclinical disease as an independent risk factor for cardiovascular 
disease. Circulation, 1995. 92(4): p. 720-726. 
28. Newman, A., et al., Coronary artery calcification in older adults with minimal clinical or 
subclinical cardiovascular disease. Journal of the American Geriatrics Society, 2000. 
48(3): p. 256-263. 
29. Cesari, M., et al., Inflammatory markers and cardiovascular disease (The Health, Aging 
and Body Composition[HealthABC] Study). American Journal of Cardiology, 2003. 92: 
p. 522-528. 
30. National Cholesterol Education Program, Third Report of the National Education 
Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood 
Cholesterol in Adults (Adult Treatment Panel III), L.a.B.I. National Heart, NIH, Editor. 
2002. 
31. Matthews, D., et al., Homeostasis model assessment: insuline resistance and beta-cell 
function from fasting glucose and insulin concentrations in man. Diabetologia, 1985. 28: 
p. 412-19. 
32. Tranquilli, A., et al., Normotensive women with intrauterine growth retardation show 
increased diastolic pressure in automated blood pressure monitoring. Am J Obstet 
Gynecol, 1993. 168(319): p. A76. 
33. David, R. and J. Collins, Differing birth weight among infants of U.S.-born Blacks, 
African-born Blacks and U.S.-born Whites. NEJM, 1997. 337(17): p. 1209-1214. 
34. Collins, J. and R. David, The differential effect of traditional risk factors on infant 
birthweight among Blacks and Whites in Chicago. Am J Public Health, 1990. 80: p. 679-
81. 
35. Shiono, P. and M. Klebanoff, Ethnic differences in preterm and very preterm delivery. 
Am J Public Health, 1986. 76(11): p. 1317-21. 
36. Abrams, B., et al., Maternal weight gain and preterm delivery. Obstetrics and 
Gynecology, 1989. 74: p. 577-83. 
76 
 37. Mosca, L., et al., Cardiovascular disease in women: a statement for healthcare 
professionals from the American Heart Association. Circulation, 1997. 96(7): p. 2468-82. 
38. Tomeo, C., et al., Reproducibility and validity of maternal recall of pregnancy-related 
events. Epidemiology, 1999. 10(6): p. 774-7. 
39. Olson, J., et al., Medical record validation of maternally reported birth characteristics 
and pregnancy-related events: a report from the Children's Cancer Group. Am J 
Epidemiol, 1997. 145(1): p. 58-67. 
 
77 
 5. DISCUSSION 
 
This cross sectional study of the association between infant characteristics and maternal 
cardiovascular risk involved the retrospective collection of pregnancy history data from a cohort 
of well-functioning older women.  In a small sub-study we were able to confirm the accuracy 
and reliability of maternal recall of infant birth weight collected on average of 57 after delivery, 
and we demonstrated that birth weight was recalled with particular precision for first births.  We 
therefore were able to combine information about pregnancy history with a well-characterized, 
robust set of cardiovascular endpoints, body composition variables, and sociodemographic 
characteristics to describe the association between delivery of a low birth weight or preterm 
infant and a woman’s remote cardiovascular disease risk. 
Our findings suggest that women who had delivered a low birth weight infant vs. a 
normal weight infant (after excluding pregnancies complicated by preeclampsia or hypertension) 
had elevations in inflammatory, metabolic and vascular measures independent of age, race, BMI, 
and lifetime exposure to cigarette smoking.  In addition, older women who delivered a first birth 
that was preterm had an increased risk for clinical cardiovascular disease after adjusting for 
sociodemographic characteristics, smoking exposure, and comorbidities.  Women who had 
delivered small and early infants appeared to have an even higher risk for clinical cardiovascular 
disease.  This was particularly true for women with hypertension, suggesting that maternal 
vascular disease may be a moderating factor.  Our results should be viewed as preliminary, as 
many of estimates were imprecise.  However, our findings raise the possibility that occult 
maternal vascular disease may contribute to LBW and preterm delivery, and could identify 
women who may benefit from screening and intervention for cardiovascular disease.   
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 To our knowledge, this study is the first to investigate the association between LBW or 
preterm delivery and maternal cardiovascular morbidity in a population of older women, 
adjusted for a variety of physical, biologic and sociodemographic correlates.  We were able to 
investigate possible pathways implicated in this association, and our findings suggest the 
importance of continued work in this area.   
 
5.1. FUTURE RESEARCH 
 
Our collection of pregnancy data via maternal recall limited our ability to characterize 
LBW and preterm delivery.  It is likely that the components of LBW,  idiopathic preterm 
delivery and growth restriction, may involve distinct or even overlapping pathways leading to the 
pregnancy characteristics we were able to measure.  Our findings suggest that perhaps the 
convergence of more than one of these pathways could lead to the worst infant prognosis (i.e., 
the smallest babies), and the highest maternal cardiovascular risk.  These questions merit 
additional investigation. 
Future studies in this area will require more comprehensive data regarding pregnancy 
characteristics.  Gestational age and additional markers of infant growth such as head 
circumference will be important to distinguish between infants that were growth restricted but 
not preterm, infants that were growth restricted and preterm, and infants that were preterm but 
grew appropriately.  There is evidence, for example, that placental insufficiency leads to fetal 
growth restriction [1] as well as preterm delivery. [2]  However, efforts to distinguish biologic 
pathways, perhaps via placental pathology [3], that lead to IUGR and/or preterm delivery will be 
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 important to further understand and investigate the relationships between these pregnancy 
outcomes and remote maternal prognosis.   
 
5.1.1. Maternal vascular disease, pregnancy outcomes and cardiovascular disease risk 
 
Our most significant findings were those suggesting that LBW or preterm delivery may 
be associated with cardiovascular risk in women through maternal vascular disease that may 
remain occult during pregnancy.  We found elevations in systolic blood pressure and pulse 
pressure in women who had delivered a LBW vs. normal weight infant many years in the past.  
In addition, we found that women with hypertension who delivered a preterm infant had a 
particularly elevated risk for clinical cardiovascular disease.  Our findings need to be replicated 
and expanded in populations where gestational age, infant birth weight, maternal body 
composition, and pregnancy complications such as preeclampsia and hypertension can be better 
characterized.   
Prospective studies of women with growth restricted or preterm pregnancies compared to 
women with normal pregnancies are needed, and analysis should be expanded to examine 
women with multiple pregnancies complicated by LBW or preterm delivery as women with 
recurrent events may have a particularly elevated cardiovascular risk.  Measurement of the same 
markers that we investigated (blood pressures, pulse pressures, insulin, glucose, IL-6, CRP) will 
be important, as well as additional markers of endothelial function.  Future studies that examine 
maternal endpoints more proximal to the growth restricted or preterm delivery will be necessary. 
Ideally, measurements would be done during pregnancy as well as five, ten, twenty, and forty 
years post partum in order to address the temporal questions that were raised by our study.  Many 
80 
 existing cohorts are available to investigate these questions, and these could be important next 
steps for additional analysis.  In particular, it will be important to determine if women who 
deliver growth restricted or preterm pregnancies enter and leave these pregnancies with 
detectable differences in vascular, metabolic or inflammatory markers.  This will help us 
determine when in the life course the differences that we detected emerge.  
 
5.1.2. Infant characteristics and maternal body composition 
 
One particularly interesting finding of this research that has not previously been described 
is the distinct body composition of women, at age 80, who delivered a LBW first infant.  While it 
is well documented that small women deliver small babies [4], it has also been found that 
maternal waist circumference is positively associated with infant birth weight. [5] These 
observations suggest that women who delivered small or preterm infants accumulated central 
adioposity after the index pregnancy, but this question warrants additional prospective 
investigation.  In addition, it will be important to investigate differential effects of body 
composition between white and black women.  Other Health ABC investigators have suggested 
that regional fat depots in blacks may have different physiologic function than those in whites 
that could contribute to higher rates of hypertension among blacks [6], and potentially to higher 
rates of poor pregnancy outcomes.    Additional investigation of the relationship between body 
composition and poor pregnancy outcomes will require study of racially diverse populations in 
order to better understand any race-specific differences. 
 
5.1.3. Infant birth weight, preterm delivery and insulin resistance 
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Consistent with the work of Lawlor, et al, [7] we found that infant birth weight was 
inversely related to maternal insulin resistance in older women.  There was no association, 
however, between infant birth weight and diabetes (p=0.848) or metabolic syndrome (p=0.667) 
suggesting a more recent pathology which had not progressed.  Mothers with gestational glucose 
intolerance tend to have heavier babies [8], and are more likely to be insulin resistant and to 
develop diabetes later in life [9].  Additional work is needed to determine any association 
between IUGR or preterm delivery and maternal insulin resistance during and after pregnancy.  
This prospective work would help identify the temporal nature and etiology of the insulin 
resistance detected in our study and the Lawlor study.  In addition, further work in this area 
should also include adequate numbers of black and white women, as our results suggested that 
insulin levels were elevated among white women many years after delivery of a LBW infant, but 
not among black women with LBW infants. 
 
5.1.4. Inflammation, LBW, preterm delivery and maternal cardiovascular risk 
 
There has been strong evidence of an association between chronic inflammation and 
preterm delivery, particularly preterm births occurring prior to 33 weeks gestation [10].  In 
addition, upregulation of inflammatory cytokines has been implicated in cardiovascular risk in 
women [11].  While the older women in our study with a LBW infant had elevations in IL-6 and 
CRP, these inflammatory markers did not appear to be associated with increased risk for clinical 
cardiovascular disease risk at age 80.  These findings appear to contradict those of Tracey [12] 
who found that CRP was associated with incident cardiovascular events among older women in 
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 the Cardiovascular Health Study, and those of Cesari [13] who found that elevations in IL-6 and 
CRP were associated with both subclinical and clinical cardiovascular disease in men and 
women combined from the Health ABC study.  We did not find elevations in IL-6 or CRP 
among women with subclinical or clinical cardiovascular disease, although median levels for 
black and white women in our study population were similar to those reported in women from 
both the Pittsburgh and Memphis field centers by Visser. [14]  Additional work is needed to 
better understand the association between delivery of a LBW or preterm infant, maternal levels 
of inflammation both during and after pregnancy which itself is an inflammatory state, and how 
these levels change over the course of a woman’s lifetime after adjustment for weight gain, 
visceral fat, insulin resistance and cigarette smoking. 
 
5.1.5. LBW, preterm delivery, cigarette smoking and maternal prognosis 
 
Cigarette smoking was an important covariate in our work as it was associated with infant 
birth weight and cardiovascular disease.  As expected, women who delivered LBW infants had 
higher rates of smoking and higher levels of smoking as measured in pack years compared to 
women with normal weight infants. [15-17]  We also found the well documented association 
between smoking and clinical cardiovascular disease. [18, 19]  Our small population of women 
who reported infants born both small and preterm had the highest rates of smoking and appeared 
to have the highest risks for clinical cardiovascular disease.  Lain, et al, has suggested that 
smoking may interact differently with normal and abnormal pregnancies, and that smoking may 
be associated with both abnormal placentation and maternal endothelial function. [20]  It is 
possible that the additional insult of nicotine during pregnancy on a maternal vascular system 
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 predisposed to reduced placental perfusion (but without the entire maternal syndrome that 
contributes to preeclampsia) may escalate the risk for growth restriction or preterm delivery. 
There is evidence that pregnancy risks associated with smoking interact with maternal age [17], 
providing some support for this notion of additive risk.  The possibility of a differential effect of 
smoking on pregnancies complicated by preterm delivery or IUGR requires further investigation, 
ideally in a large prospective study of mothers with well characterized pregnancy, cotinine, and 
vascular measures and long term follow up. 
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 6. APPLICATION TO PUBLIC HEALTH 
 
Describing an association between pregnancy outcomes and maternal chronic disease risk 
contributes new insight into the persistent public health challenges of low birth weight and 
preterm delivery.  This work builds on the emerging evidence that occult maternal vascular 
disease may lead to placental insufficiency, resulting in infants born too small or too early.  Our 
work contributes new information by examining intermediate cardiovascular measures and 
pathways that may moderate this relationship.  Interventions to reduce cardiovascular risk, such 
as smoking cessation and increased physical activity, may also alter risks for poor pregnancy 
outcomes.   
In addition, if an undetected predisposition for chronic disease is associated with LBW or 
preterm delivery, these outcomes could help identify a subset of women who could benefit from 
screening and intervention to reduce cardiovascular risk.  Identification of high risk women prior 
to the menopause, when clinical attention to these risks typically begins, would help initiate 
treatment perhaps in time to delay onset of disease.  Pregnancy care is often the only clinical care 
a woman receives during her reproductive years.  Poor pregnancy outcomes could mark women 
who should be screened for cardiovascular risk at a relatively young age and referred for on-
going routine clinical intervention following the post partum visit.   
 This work also contributes potentially important information to reduce racial disparities 
in pregnancy and cardiovascular outcomes.  The rates of low birth weight, preterm delivery and 
cardiovascular disease among black women are about twice that of white women.  Our findings 
suggest that there may be some race-specific risks that moderate the association between 
pregnancy outcomes and cardiovascular disease, and these warrant additional investigation.   
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  Our study suggests that infant outcomes might be affected by a mother’s overall health 
status as she enters pregnancy.  If these results are confirmed by other investigators and in other 
populations, public health efforts to improve the cardiovascular health status of young women of 
reproductive age may help reduce the burden of poor pregnancy outcomes as well as improve the 
health of women as they age. 
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